This is a Validated Antibody Database (VAD) review about human ER, based on 260 published articles (read how Labome selects the articles), using ER antibody in all methods. It is aimed to help Labome visitors find the most suited ER antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ER synonym: ER; ESR; ESRA; ESTRR; Era; NR3A1

Knockout validation
Invitrogen
mouse monoclonal (AER314)
  • western blot knockout validation; human; fig 4
In order to identify and study the expression of a variant estrogen receptor lacking exon 4 in ovarian carcinoma cells, Invitrogen ER antibody (Neomarkers, AER314) was used in western blot knockout validation on human samples (fig 4). Clin Cancer Res (1996) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-10)
  • immunohistochemistry knockout validation; mouse; 1:250; loading ...; fig 5a
  • immunohistochemistry - frozen section; mouse; 1:250; loading ...; fig 5a
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in immunohistochemistry knockout validation on mouse samples at 1:250 (fig 5a) and in immunohistochemistry - frozen section on mouse samples at 1:250 (fig 5a). elife (2021) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-10)
  • western blot knockout validation; human; fig 1
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot knockout validation on human samples (fig 1). PLoS ONE (2016) ncbi
Invitrogen
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; rat; fig 4a
Invitrogen ER antibody (Thermo Fisher Scientific, MA5-14501) was used in immunohistochemistry on rat samples (fig 4a). Int J Mol Sci (2021) ncbi
mouse monoclonal (1D5, 6F11)
  • western blot; human; 1:1000; fig s2e
Invitrogen ER antibody (Thermo Fisher Scientific, MA5 14104) was used in western blot on human samples at 1:1000 (fig s2e). Nat Commun (2021) ncbi
mouse monoclonal (33)
  • western blot; mouse; 1:30; loading ...; fig 2b
Invitrogen ER antibody (Invitrogen, MA-1-310) was used in western blot on mouse samples at 1:30 (fig 2b). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 1
Invitrogen ER antibody (LabVision, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Breast Cancer Res (2020) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human; loading ...; fig 7b
Invitrogen ER antibody (Thermo Scientific, RM-9101) was used in western blot on human samples (fig 7b). Cell (2019) ncbi
domestic rabbit monoclonal (Sp1)
  • other; human; loading ...; fig 4c
Invitrogen ER antibody (Lab Vision, RM-9101-S) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (1D5)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
In order to elucidate the clinical importance of IDO1 protein in hormone receptor-positive breast cancer, Invitrogen ER antibody (Thermo-Scientific, 1D5) was used in immunohistochemistry - paraffin section on human samples at 1:50. J Immunother Cancer (2017) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human; 1:10; loading ...; fig 2a
In order to describe a microfluidic western blot for an eight-plex protein panel for individual circulating tumor cells derived from estrogen receptor-positive breast cancer patients, Invitrogen ER antibody (ThermoScientific, RM-9101-S0) was used in western blot on human samples at 1:10 (fig 2a). Nat Commun (2017) ncbi
mouse monoclonal (EVG F9)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:150; loading ...; tbl 1
In order to explore the mechanisms of estrogens in modulating neuronal somata size in paravaginal ganglia, Invitrogen ER antibody (Thermo Scientific, MA3-310) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:150 (tbl 1). Biomed Res Int (2017) ncbi
domestic rabbit monoclonal (Sp1)
  • reverse phase protein lysate microarray; human; loading ...; fig 7a
In order to characterize the molecular identity of uterine carcinosarcomas., Invitrogen ER antibody (Lab Vision, RM-9101-S) was used in reverse phase protein lysate microarray on human samples (fig 7a). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:200; loading ...; fig 5b
In order to examine the cross talk between the aryl hydrocarbon receptor and the estrogen receptor on a mRNA transcriptome wide scale, Invitrogen ER antibody (Thermo Fisher Scientific, PA1-309) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 5b). J Steroid Biochem Mol Biol (2017) ncbi
mouse monoclonal (33)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 6a
In order to ask if topical dehydroepiandrosterone ameliorates Meibomian gland dysfunction caused by isotretinoin, Invitrogen ER antibody (Thermo Fisher Scientific, MA1-310) was used in immunohistochemistry - paraffin section on rat samples (fig 6a). Ann Anat (2017) ncbi
domestic rabbit monoclonal (Sp1)
  • reverse phase protein lysate microarray; human; loading ...; fig 3a
In order to describe the features of 228 primary cervical cancers, Invitrogen ER antibody (Lab Vision, RM-9101-S) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human; loading ...; fig 4a
In order to study the interaction between UXT and LOX-PP, Invitrogen ER antibody (Thermo Scientific, RM-9101-SO) was used in western blot on human samples (fig 4a). J Cell Biochem (2017) ncbi
mouse monoclonal (1D5)
  • immunocytochemistry; human; 1:25; fig 6
In order to discuss estrogen receptor regulation and function in normal breast and breast cancer, Invitrogen ER antibody (Thermo Fisher Scientific, 1D5) was used in immunocytochemistry on human samples at 1:25 (fig 6). Oncotarget (2017) ncbi
domestic rabbit monoclonal (Sp1)
  • flow cytometry; human; 1:50; fig ED7c
  • immunoprecipitation; human
  • western blot; human; 1:500; loading ...; fig 2c, 4b, 4e,ED4b
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., Invitrogen ER antibody (Thermo/Fisher Scientific, SP1) was used in flow cytometry on human samples at 1:50 (fig ED7c), in immunoprecipitation on human samples and in western blot on human samples at 1:500 (fig 2c, 4b, 4e,ED4b). Nature (2017) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Invitrogen ER antibody (Lab Vision, RM-9101-S) was used in western blot on human samples . Cell Syst (2017) ncbi
mouse monoclonal (TE111.5D11)
  • western blot; human; loading ...; fig s5c
In order to investigate the contribution of cancer-associated long non-coding RNAs in estrogen receptor signaling, Invitrogen ER antibody (Thermo Fisher Scientific, TE111.5D11) was used in western blot on human samples (fig s5c). Sci Rep (2016) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - frozen section; domestic rabbit; 1:200; loading ...; fig 4a
  • western blot; domestic rabbit; 1:200; loading ...; fig 4d
In order to show that rabbits fed a high-cholesterol diet have higher levels of brain 27-hydroxycholesterol, increased levels of neurodegeneration in the hippocampus, changes in hippocampal estrogen receptor expression, and a decrease in hippocampal mitochond, Invitrogen ER antibody (ThermoScientific, MA1-27107) was used in immunohistochemistry - frozen section on domestic rabbit samples at 1:200 (fig 4a) and in western blot on domestic rabbit samples at 1:200 (fig 4d). J Alzheimers Dis (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; domestic rabbit; 1:200; loading ...; fig 5a
In order to show that rabbits fed a high-cholesterol diet have higher levels of brain 27-hydroxycholesterol, increased levels of neurodegeneration in the hippocampus, changes in hippocampal estrogen receptor expression, and a decrease in hippocampal mitochond, Invitrogen ER antibody (ThermoScientific, PA5-16476) was used in immunohistochemistry - frozen section on domestic rabbit samples at 1:200 (fig 5a). J Alzheimers Dis (2017) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; tbl 1
In order to examine the histological subnuclear morphology of active and inactive progesterone receptor in archival breast cancer samples, Invitrogen ER antibody (Thermo Scientific, MA1-39540) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 1). ESMO Open (2016) ncbi
mouse monoclonal (1D5)
  • western blot; human; 1:500; loading ...; tbl 1
In order to study the effects of prenatal testosterone on luteinizing hormone secretion in sheep., Invitrogen ER antibody (Thermo Scientific, MS-354) was used in western blot on human samples at 1:500 (tbl 1). Endocrinology (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 2a
In order to use mice to characterize the sexually dimorphic area in the dorsal hypothalamus, Invitrogen ER antibody (Thermo Fisher, PA1-308) was used in immunohistochemistry on mouse samples (fig 2a). Endocrinology (2016) ncbi
mouse monoclonal (TE111.5D11)
  • western blot; mouse; loading ...; fig 1d
  • immunohistochemistry - frozen section; human; loading ...; fig 1a
In order to explore the role of estrogen-induced deregulated myelopoiesis in cancer, Invitrogen ER antibody (ThermoFisher Scientific, TE111.5D11) was used in western blot on mouse samples (fig 1d) and in immunohistochemistry - frozen section on human samples (fig 1a). Cancer Discov (2017) ncbi
mouse monoclonal (TE111.5D11)
  • flow cytometry; human; loading ...; fig 1a
In order to assess the role of host membrane trafficking to latent Epstein-Barr virus infection of B cells, Invitrogen ER antibody (Thermo Scientific, TE111.5D11) was used in flow cytometry on human samples (fig 1a). J Gen Virol (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; loading ...; fig st1
In order to investigate the interaction between breast cancer subtype and treatment using data from a breast cancer trial randomizing women to adjuvant chemotherapy, Invitrogen ER antibody (Thermo scientific, SP1) was used in immunohistochemistry - paraffin section on human samples (fig st1). Clin Cancer Res (2017) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 2
In order to study the correlation of miR-221/222, estrogen receptor and TIMP3 in breast cancer., Invitrogen ER antibody (Thermo Fisher Scientific, ER-RM-9101-S1) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Mol Diagn Ther (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human; fig 2
In order to study inhibition in hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer cells with acquired resistance to Paclitaxel by effects of CDK4/6, Invitrogen ER antibody (Thermo Scientific, RM-9101-S) was used in western blot on human samples (fig 2). J Cancer (2016) ncbi
mouse monoclonal (1D5)
  • immunohistochemistry; human; 1:300; fig 2
In order to study 3 cases of uterine adenomyosis/adenomyotic cysts of the cervical stump leading to serous carcinoma, Invitrogen ER antibody (Thermo, 1D5) was used in immunohistochemistry on human samples at 1:300 (fig 2). Diagn Pathol (2016) ncbi
mouse monoclonal (33)
  • immunocytochemistry; mouse; 1:50; fig 5
In order to characterize protection of astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression by tibolone, Invitrogen ER antibody (Thermo Scientific, MA1-310) was used in immunocytochemistry on mouse samples at 1:50 (fig 5). Mol Cell Endocrinol (2016) ncbi
mouse monoclonal (33)
  • flow cytometry; human; 1:20
In order to characterize enhancement of transcriptome variability and metastatic fitness by highly variable cancer subpopulations, Invitrogen ER antibody (Thermo, MA1310) was used in flow cytometry on human samples at 1:20. Nat Commun (2016) ncbi
mouse monoclonal (TE111.5D11)
  • chromatin immunoprecipitation; mouse; fig 1a
In order to report the global transcription rates and chromatin changes that accompany the transformation process induced by MLL-ENL, Invitrogen ER antibody (Thermo Scientific, TE111.5D11) was used in chromatin immunoprecipitation on mouse samples (fig 1a). Cell Rep (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:50; fig s2
In order to identify prognostic indicators of resected early stage 'pure' and 'mixed' lobular breast cancer by using subpopulation treatment effect pattern plot (STEPP) analysis of Ki67 histology assay, Invitrogen ER antibody (Thermo Sc. Labvision, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig s2). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 1
In order to research the association of breast cancer susceptibility and polymorphisms of glutathione S-transferase pi and toll-like receptors 2 and 9, Invitrogen ER antibody (ThermoFisher Scientific, MA1-39540) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1). Oncol Lett (2016) ncbi
mouse monoclonal (33)
  • western blot; pigs ; fig 3
In order to characterize a feedforward mechanism at the G protein-coupled estrogen receptor 1 that controls estrogen enhaced linkage in the vascular endothelial calmodulin network, Invitrogen ER antibody (Pierce, MA1-310) was used in western blot on pigs samples (fig 3). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100; fig s1
In order to utilize ovarian cancer xenograft models to study dynamic modulation of phosphoprotein expression, Invitrogen ER antibody (Neomarkers, RM-9101-S1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1). BMC Cancer (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:100; loading ...
In order to explore the relationship between tumor-infiltrating lymphocytes and the clinical outcomes of triple-negative breast cancers, Invitrogen ER antibody (Thermoscientific, SP1) was used in immunohistochemistry on human samples at 1:100. Breast Cancer Res Treat (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; tbl 3
In order to compare and correlate AIB1 expression before and after the development of tamoxifen resistance, Invitrogen ER antibody (ThermoScientific, RM-9101) was used in immunohistochemistry on human samples (tbl 3). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to characterize diagnosis of asymptomatic benign papilloma without atypia via ultrasonography-guided 14-gauge core needle biopsy to determine a possible subgroup to monitor by observation, Invitrogen ER antibody (Thermo Scientific, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Ann Surg Oncol (2016) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; cat; 1:125; loading ...; tbl 4
In order to develop an assay to measure serum HER2 in order to diagnose cats with mammary carcinomas, Invitrogen ER antibody (Thermo Scientific, 6F11) was used in immunohistochemistry - paraffin section on cat samples at 1:125 (tbl 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 1
In order to elucidate the role of Runx2 during the early stages of breast cancer and metastasis, Invitrogen ER antibody (Thermo Scientific, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Pathol Oncol Res (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunocytochemistry; human; 1:10; fig s13b
In order to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture, Invitrogen ER antibody (Labvision, RM-9101-S) was used in immunocytochemistry on human samples at 1:10 (fig s13b). Nat Commun (2015) ncbi
mouse monoclonal (TE111.5D11)
  • immunohistochemistry - paraffin section; chicken; 4 ug/ml; fig 3
In order to examine the expression of progesterone receptor isoforms and estrogen receptor alpha in chickens, Invitrogen ER antibody (NeoMarkers, TE111.5D11) was used in immunohistochemistry - paraffin section on chicken samples at 4 ug/ml (fig 3). Acta Histochem (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human
In order to study estrogen receptor-positive metastatic breast cancer in postmenopausal patients and abiraterone acetate, exemestane or a combination of both, Invitrogen ER antibody (Thermo Fisher, RM-9101-S) was used in immunohistochemistry - paraffin section on human samples . Ann Oncol (2016) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry; cat; 1:100; loading ...; fig 1a
In order to describe the clinical, pathological, and immunophenotypic features collected from 61 queens with feline mammary carcinoma, Invitrogen ER antibody (Thermo Scientific, 6 F11) was used in immunohistochemistry on cat samples at 1:100 (fig 1a). Tumour Biol (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to analyze metastatic breast cancer and the expression of lipid metabolism-related proteins, Invitrogen ER antibody (Thermo Scientific, RM-9101-S) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human
In order to analyze how aggressiveness and invasiveness of human breast carcinoma is correlated with hexokinase and phosphofructokinase kinase and intracellular distribution, Invitrogen ER antibody (Thermo Scientific, SP1) was used in immunohistochemistry - paraffin section on human samples . Oncotarget (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; loading ...
In order to report the demographic characteristics, recurrence pattern, and survival rate in Colombian females with breast cancer, Invitrogen ER antibody (Thermo scientific, SP1) was used in immunohistochemistry on human samples . Ecancermedicalscience (2015) ncbi
mouse monoclonal (TE111.5D11)
  • chromatin immunoprecipitation; mouse; fig 1h
  • western blot; mouse; fig 1d
In order to investigate the nuclear function of CEP290, Invitrogen ER antibody (Thermo Scientific, TE111.5D11) was used in chromatin immunoprecipitation on mouse samples (fig 1h) and in western blot on mouse samples (fig 1d). J Clin Invest (2015) ncbi
mouse monoclonal (TE111.5D11)
  • chromatin immunoprecipitation; mouse; fig 1h
  • western blot; mouse; fig 1d
In order to elucidate how Myb contributes to poor prognosis of colorectal cancer, Invitrogen ER antibody (Thermo Scientific, TE111.5D11) was used in chromatin immunoprecipitation on mouse samples (fig 1h) and in western blot on mouse samples (fig 1d). Oncogene (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:100
In order to evaluate the expression of CD24, CD44, CD133 and ALDH1 in invasive ductal carcinoma of the breast, Invitrogen ER antibody (Thermo Scientific, RM-9101-S1) was used in immunohistochemistry on human samples at 1:100. Pathol Res Pract (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:60
In order to investigate global expression changes during metastatic disease progression, Invitrogen ER antibody (Thermo Fisher Scientific, RM9101S) was used in immunohistochemistry - paraffin section on human samples at 1:60. Clin Cancer Res (2015) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry; pigs ; fig s5
In order to characterize porcine mammary epithelial cells in vitro and tumor formation in vivo and neoplastic transformation, Invitrogen ER antibody (ThermoFisher Scientific, 6F11) was used in immunohistochemistry on pigs samples (fig s5). BMC Cancer (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human; fig 2
In order to determine stress resistance to breast cancer cells and neuroblastoma by BAG3 function and estrogen receptor alpha that regulates non-canonical autophagy, Invitrogen ER antibody (Thermo Scientific, RM9101S0) was used in western blot on human samples (fig 2). Cell Death Dis (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:25; loading ...; fig 1c
In order to discuss methods to treat triple-negative breast cancer, Invitrogen ER antibody (Thermo Scientific, clone SP1) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig 1c). J Biomed Sci (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:500
In order to investigate markers expressed by stromal cells in breast cancer patients, Invitrogen ER antibody (NeoMarkers, RM9101) was used in immunohistochemistry on human samples at 1:500. Mol Clin Oncol (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
In order to characterize triple-negative breast cancer and the role of epithelial-mesenchymal transition markers, Invitrogen ER antibody (Thermo Lab Vision, RM-9101-S) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Breast Cancer Res Treat (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:50
In order to assess the clinicopathological and immunohistochemical characteristics, and the clinical outcomes, between screen-detected and symptomatic DCIS, Invitrogen ER antibody (Thermo Scientific Lab Vision, RM-9101-S) was used in immunohistochemistry - paraffin section on human samples at 1:50. Breast Cancer Res Treat (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:500
Invitrogen ER antibody (Thermo Scientific, SP1) was used in immunohistochemistry on human samples at 1:500. Breast (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human
In order to discuss how to treat the four types of breast cancer, Invitrogen ER antibody (Thermo Scientific Lab Vision, SP1) was used in immunohistochemistry - paraffin section on human samples . Niger J Clin Pract (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunocytochemistry; human; 1:50
In order to characterize circulating tumor cells isolated using the CellSearch system, Invitrogen ER antibody (Thermo Scientific, RM-9101-S1) was used in immunocytochemistry on human samples at 1:50. J Transl Med (2015) ncbi
mouse monoclonal (33)
  • western blot; human
In order to study the role of Src homology phosphotyrosyl phosphatase 2 (SHP2) in triple negative breast cancers, Invitrogen ER antibody (Thermo Scientific, MA1-310) was used in western blot on human samples . BMC Cancer (2015) ncbi
mouse monoclonal (EVG F9)
  • immunohistochemistry; domestic rabbit
In order to examine the effect of estrogen on amoratase expression in the pubococcygeus and bulbospongiosus muscles of female rabbits, Invitrogen ER antibody (Thermo Scientific, MA3-310) was used in immunohistochemistry on domestic rabbit samples . Cell Biochem Funct (2015) ncbi
mouse monoclonal (6F11)
  • immunocytochemistry; rat
Invitrogen ER antibody (Thermo Scientific, 6F11) was used in immunocytochemistry on rat samples . Exp Oncol (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:80
In order to compare the immunohistochemical and genetic profiles found in the three types of endometrial carcinomas, Invitrogen ER antibody (Thermo Scientific, SP1) was used in immunohistochemistry on human samples at 1:80. Gynecol Oncol (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to identify clinicopathologic factors associated with sentinel lymph node metastasis, Invitrogen ER antibody (LabVision, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Cancer Res Treat (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human
In order to determine of the effects of 1-year endocrine therapy in patients with breast cancer, Invitrogen ER antibody (Lab Vision, SP1) was used in immunohistochemistry - paraffin section on human samples . Pathol Oncol Res (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 4
In order to characterize different breast cancer subtypes and differential expression of lipid metabolism-related proteins, Invitrogen ER antibody (Thermo Scientific, RM-9101-S) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 4). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; tbl 3
In order to determine poor outcome in breast cancer patients in regards to upregulation of IGF-1R expression in neoadjuvant therapy, Invitrogen ER antibody (NeoMarkers, RM-9101-S1) was used in immunohistochemistry - paraffin section on human samples (tbl 3). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:50
In order to evaluate the presence of cancer stem cells and EMT markers as prognostic markers for breast metaplastic carcinoma, Invitrogen ER antibody (Neomarker, RM-9101-R7) was used in immunohistochemistry on human samples at 1:50. Breast Cancer Res Treat (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:80
In order to describe a patient diagnosed with a noninvasive intestinal-type mucinous ovarian borderline tumor presenting with pleural metastases, Invitrogen ER antibody (Thermo Fisher Scientific, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:80. Int J Gynecol Pathol (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:400
In order to discuss the use of an intraoperative frozen section procedure during treatment for breast cancer, Invitrogen ER antibody (Thermo, SP1) was used in immunohistochemistry on human samples at 1:400. Balkan Med J (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:100; loading ...
In order to identify the cancer-associated fibroblast phenotype in different subtypes of breast cancer., Invitrogen ER antibody (Thermo Scientific, RM-9101) was used in immunohistochemistry on human samples at 1:100. Breast Cancer Res Treat (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human; fig 3
In order to use a cell culture model for aromatase inhibitor-resistant breast cancer to show how fulvestrant treatment and cross-resistance between exemestane and letrozole shows sensitivity, Invitrogen ER antibody (Neomarkers, RM-9101) was used in western blot on human samples (fig 3). Int J Oncol (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:200
In order to evaluate the prevalence, characteristics, prognosis, and effective treatment modalities in patients with primary squamous cell carcinoma of the breast, Invitrogen ER antibody (Zymed, SP1) was used in immunohistochemistry on human samples at 1:200. Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry; human
  • immunohistochemistry; rat
Invitrogen ER antibody (Thermo Scientific, 6F11) was used in immunohistochemistry on human samples and in immunohistochemistry on rat samples . Exp Oncol (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:50
Invitrogen ER antibody (Thermo Fisher Scientific, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:50. Oncotarget (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:500
Invitrogen ER antibody (Thermo Scientific, SP1) was used in immunohistochemistry on human samples at 1:500. BMC Womens Health (2014) ncbi
mouse monoclonal
  • immunohistochemistry; human; 1:3000
In order to assess the impact on maternal behavior of neonatal manipulation of ERalpha in females that had experienced low versus high levels of postnatal maternal licking and grooming, Invitrogen ER antibody (Life Technologies, 49-1002) was used in immunohistochemistry on human samples at 1:3000. Dev Neurobiol (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen ER antibody (Thermo Scientific, SP-1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Am J Clin Pathol (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human
In order to study genes that regulate vesicle formation in breast cancer, Invitrogen ER antibody (Thermo, SP1) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (33)
  • immunocytochemistry; human; 1:200
  • western blot; mouse; 1:200
In order to analyze children born with congenital genitourinary tract masculinization disorders by array-comparative genomic hybridization, Invitrogen ER antibody (Thermo, MA1-310) was used in immunocytochemistry on human samples at 1:200 and in western blot on mouse samples at 1:200. Nat Med (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:80
Invitrogen ER antibody (Thermo Scientific, SP1) was used in immunohistochemistry on human samples at 1:80. Virchows Arch (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:500
In order to determine breast cancr stem cells and the lack of correlation of stem cell markers, Invitrogen ER antibody (LabVision, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:500. Br J Cancer (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human
In order to establish a tissue quality index as an intrinsic control for measurement of different effects of preanalytical variables on FFPE tissue, Invitrogen ER antibody (Thermo, SP1) was used in immunohistochemistry - paraffin section on human samples . Lab Invest (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:200
In order to assess growth hormone-releasing hormone receptors in different types of breast cancer, Invitrogen ER antibody (Lab Vision, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:200. APMIS (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen ER antibody (Labvision, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mod Pathol (2014) ncbi
mouse monoclonal (AER314)
  • western blot; human; fig s8
In order to report that ERAP treatment suppresses tamoxifen resistance and enhances tamoxifen responsiveness in ERalpha-positive breast cancer cells, Invitrogen ER antibody (Thermo Fisher, AER314) was used in western blot on human samples (fig s8). Nat Commun (2013) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human
In order to study salivary duct carcinoma with rhabdoid features, Invitrogen ER antibody (Thermo Scientific, SP-1) was used in immunohistochemistry on human samples . Head Neck (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:60
Invitrogen ER antibody (Thermo Fisher, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:60. Int J Cancer (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
In order to study triple negative breast cancer in Chinese women, Invitrogen ER antibody (Zymed, clone SP1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). Int J Clin Exp Pathol (2013) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human
Invitrogen ER antibody (Neomarkers, SP1) was used in immunohistochemistry - paraffin section on human samples . J BUON (2013) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:500; tbl 1
In order to learn about a new potential marker for low risk of invasion in ductal carcinoma in situ is called basal cytokeratin, Invitrogen ER antibody (Thermo Scientific, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 1). Clinics (Sao Paulo) (2013) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human
In order to report and characterize two cases of accessory breast cancer occurring concurrently with primary invasive breast cancer, Invitrogen ER antibody (Zymed, SP1) was used in immunohistochemistry on human samples . Cancer Biol Med (2012) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:50; fig 1
In order to examine the expression of SRC-3 in epithelial ovarian cancers and its influence on outcome or the efficacy of treatment, Invitrogen ER antibody (Neomarkers, RM-9101-S1) was used in immunohistochemistry on human samples at 1:50 (fig 1). Br J Cancer (2013) ncbi
mouse monoclonal (1D5)
  • immunohistochemistry; human; tbl 1
In order to report the case of primary acinic cell carcinoma of the breast in a 38-year-old woman, Invitrogen ER antibody (Zymed, 1D5) was used in immunohistochemistry on human samples (tbl 1). Int J Surg Pathol (2014) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human
In order to discuss the role of breast cancer-derived IgG in cancer development, Invitrogen ER antibody (Zymed Laboratories, 491002) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to characterize Brazilian breast cancer cell lines, Invitrogen ER antibody (Neomarkers, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncol Rep (2013) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to characterize Brazilian breast cancer cell lines, Invitrogen ER antibody (Neomarkers, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncol Rep (2013) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2d
  • immunohistochemistry; human; 1:1000
  • western blot; human; 1:500; loading ...; fig 1b
In order to study the sensitivity of the rabbit monoclonal antibodies SP1 and 1D5 towards the estrogen receptor, Invitrogen ER antibody (Thermo, SP1) was used in immunohistochemistry - paraffin section on human samples (fig 2d), in immunohistochemistry on human samples at 1:1000 and in western blot on human samples at 1:500 (fig 1b). Appl Immunohistochem Mol Morphol (2013) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:1000
In order to present two cases of leiomyomatosis peritonealis, Invitrogen ER antibody (Neomarkers, SP1) was used in immunohistochemistry on human samples at 1:1000. Clin Med Insights Case Rep (2012) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to describe a case of endocervicosis in a 37-year-old woman, Invitrogen ER antibody (NeoMarkers, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Diagn Pathol (2011) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:50
In order to study EGFR gene in triple negative breast cancer and its therapeutic application, Invitrogen ER antibody (Neomarker, RM9101-S) was used in immunohistochemistry - paraffin section on human samples at 1:50. Breast Cancer Res (2011) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human; fig 1
In order to study the interaction between prolactin and oestrogen in breast cancer cells, Invitrogen ER antibody (Lab Vision, SP1) was used in western blot on human samples (fig 1). Endocr Relat Cancer (2010) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to discuss factors that influence heat-induced antigen retrieval, Invitrogen ER antibody (Labvision, SP1) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Pathology (2010) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 3
  • immunohistochemistry; human; 1:400
In order to study the role of CLDN2 expression in breast cancer development and progression, Invitrogen ER antibody (Thermo Scientific, SP1) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 3) and in immunohistochemistry on human samples at 1:400. Histopathology (2008) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - frozen section; human; 1:100
  • immunohistochemistry; human; 1:100
In order to evaluate different fixation and antigen retrieval methods for immmunohistochemical studies on frozen tissues, Invitrogen ER antibody (Lab Vision, 6F11) was used in immunohistochemistry - frozen section on human samples at 1:100 and in immunohistochemistry on human samples at 1:100. Am J Clin Pathol (2008) ncbi
domestic rabbit monoclonal (Sp1)
  • immunocytochemistry; human; fig 5
  • immunohistochemistry; human
  • western blot; human
In order to develop an estrogen receptor-alpha-positive model of breast cancer using human mammary epithelial cells, Invitrogen ER antibody (Neomarkers, SP1) was used in immunocytochemistry on human samples (fig 5), in immunohistochemistry on human samples and in western blot on human samples . Breast Cancer Res (2007) ncbi
mouse monoclonal (1D5)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss how H-ras contributes to the transformation of human mammary epithelial cells, Invitrogen ER antibody (Zymed, ID5) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer Cell Int (2006) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; 1:80; fig 6
In order to present the case of a patient with an epithelioid trophoblastic tumor, Invitrogen ER antibody (Zymed, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:80 (fig 6). Am J Surg Pathol (2004) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; rat; tbl 1
In order to determine the changes in morphology and expression of androgen receptor and estrogen receptor alpha in the body of the rat penis exposed neonatally to diethylstilbestrol, Invitrogen ER antibody (Zymed, 6F11) was used in immunohistochemistry - paraffin section on rat samples (tbl 1). Biol Reprod (2004) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; tbl 2
In order to compare tumors involving endometrium and ovary and metastatic endometrial tumors, Invitrogen ER antibody (Zymed, 6F11) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Int J Gynecol Cancer (2003) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to determine the clinical, pathological, and immunohistochemical features of breast hamartomas, Invitrogen ER antibody (Zymed, 6F11) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Histopathology (2002) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; fig 1
In order to compare matched primary peritoneal serous papillary carcinoma and ovarian serous papillary cancer samples, Invitrogen ER antibody (Zymed, 6F11) was used in immunohistochemistry - paraffin section on human samples (fig 1). Int J Gynecol Pathol (2001) ncbi
mouse monoclonal (AER314)
  • western blot knockout validation; human; fig 4
In order to identify and study the expression of a variant estrogen receptor lacking exon 4 in ovarian carcinoma cells, Invitrogen ER antibody (Neomarkers, AER314) was used in western blot knockout validation on human samples (fig 4). Clin Cancer Res (1996) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-10)
  • western blot; human; 1:200; loading ...; fig 3a
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples at 1:200 (fig 3a). Int J Mol Sci (2022) ncbi
mouse monoclonal (F-10)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig e2d
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig e2d). Nat Cancer (2022) ncbi
mouse monoclonal (F-10)
  • chromatin immunoprecipitation; human; loading ...; fig 4j, 5p
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002x) was used in chromatin immunoprecipitation on human samples (fig 4j, 5p). Nat Commun (2022) ncbi
mouse monoclonal (D-12)
  • immunoprecipitation; human; loading ...; fig 5j
Santa Cruz Biotechnology ER antibody (Santa Cruz, SC8005) was used in immunoprecipitation on human samples (fig 5j). Nat Commun (2022) ncbi
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology ER antibody (Santa Cruz, HC-20) was used in western blot on human samples (fig 1a). Cancers (Basel) (2022) ncbi
mouse monoclonal (F-10)
  • western blot; mouse; 1:1000; loading ...; fig 1f
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on mouse samples at 1:1000 (fig 1f). Cells (2021) ncbi
mouse monoclonal (2Q418)
  • western blot; human; loading ...; fig 1c
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, sc-71064) was used in western blot on human samples (fig 1c). BMC Cancer (2021) ncbi
mouse monoclonal (D-12)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 8a
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8005) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 8a). Am J Transl Res (2021) ncbi
mouse monoclonal (F-10)
  • immunohistochemistry; mouse; loading ...
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, 8002) was used in immunohistochemistry on mouse samples . Clin Cancer Res (2021) ncbi
mouse monoclonal (F-10)
  • immunohistochemistry knockout validation; mouse; 1:250; loading ...; fig 5a
  • immunohistochemistry - frozen section; mouse; 1:250; loading ...; fig 5a
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in immunohistochemistry knockout validation on mouse samples at 1:250 (fig 5a) and in immunohistochemistry - frozen section on mouse samples at 1:250 (fig 5a). elife (2021) ncbi
mouse monoclonal (C-311)
  • immunohistochemistry; human; loading ...
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, C-311) was used in immunohistochemistry on human samples . Oncogene (2020) ncbi
mouse monoclonal (C-311)
  • immunohistochemistry; cat; 1:50; loading ...; tbl 2
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-787) was used in immunohistochemistry on cat samples at 1:50 (tbl 2). BMC Cancer (2019) ncbi
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, HC-20) was used in western blot on human samples (fig 1a). Breast Cancer Res (2019) ncbi
mouse monoclonal (2Q418)
  • immunohistochemistry; human; 1:200; loading ...; fig 1b
Santa Cruz Biotechnology ER antibody (Santa, SC71064) was used in immunohistochemistry on human samples at 1:200 (fig 1b). Breast Cancer Res (2019) ncbi
mouse monoclonal (2Q418)
  • western blot; mouse; loading ...; fig 4c
Santa Cruz Biotechnology ER antibody (Santa, SC-71064) was used in western blot on mouse samples (fig 4c). Nutrients (2019) ncbi
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-543) was used . Sci Adv (2019) ncbi
  • immunohistochemistry; human; loading ...; fig 3c
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, SC-543) was used in immunohistochemistry on human samples (fig 3c). Oncogene (2018) ncbi
mouse monoclonal (D-12)
  • immunocytochemistry; human; 1:50
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology ER antibody (SantaCruz, sc8005) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples (fig 2a). Breast Cancer Res Treat (2018) ncbi
mouse monoclonal (D-12)
  • western blot; human; loading ...; fig 1c
Santa Cruz Biotechnology ER antibody (SantaCruz, sc-8005) was used in western blot on human samples (fig 1c). Oncotarget (2017) ncbi
  • western blot; mouse; 1:1000; loading ...; fig s6a
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-543) was used in western blot on mouse samples at 1:1000 (fig s6a). Sci Rep (2017) ncbi
mouse monoclonal (D-12)
  • EMSA; human; loading ...; fig 8a
In order to characterize pseudoexfoliation syndrome-associated genetic variants of lysyl oxidase-like 1, Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8005X) was used in EMSA on human samples (fig 8a). Nat Commun (2017) ncbi
  • chromatin immunoprecipitation; human; loading ...; fig s1d
  • western blot; human; loading ...; fig s5b
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-543) was used in chromatin immunoprecipitation on human samples (fig s1d) and in western blot on human samples (fig s5b). Science (2017) ncbi
mouse monoclonal (10H12B10)
  • western blot; human; 1:1000; loading ...; fig 7d
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-130072) was used in western blot on human samples at 1:1000 (fig 7d). Front Pharmacol (2017) ncbi
  • western blot; human; loading ...; fig s4a
In order to identify sex-related factors that regulate the severity of facioscapulohumeral muscular dystrophy, Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-543) was used in western blot on human samples (fig s4a). J Clin Invest (2017) ncbi
mouse monoclonal (D-12)
  • immunohistochemistry - paraffin section; human; 1:50; fig 4a
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8005) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4a). Reprod Biol Endocrinol (2017) ncbi
mouse monoclonal (C-311)
  • immunocytochemistry; pigs ; 1:50; fig 2
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, C-311) was used in immunocytochemistry on pigs samples at 1:50 (fig 2). PLoS ONE (2017) ncbi
  • immunohistochemistry; rat; loading ...; fig 102
In order to outline the protocols for antibodies used for immunohistochemical studies, Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-543) was used in immunohistochemistry on rat samples (fig 102). J Toxicol Pathol (2017) ncbi
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology ER antibody (SantaCruz, sc-543) was used in western blot on human samples (fig 4a). Oncotarget (2017) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; 1:300; fig 1
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-56836) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 1). Arch Med Sci (2017) ncbi
  • western blot; human; 1:500; loading ...; fig 1a
Santa Cruz Biotechnology ER antibody (Santa Cruz biotechnology, HC-20) was used in western blot on human samples at 1:500 (fig 1a). Mol Cell Endocrinol (2017) ncbi
  • chromatin immunoprecipitation; human; loading ...; fig 3c
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-543) was used in chromatin immunoprecipitation on human samples (fig 3c). Nucleic Acids Res (2017) ncbi
  • immunohistochemistry; human; fig 3d
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-543) was used in immunohistochemistry on human samples (fig 3d). Exp Cell Res (2017) ncbi
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-543) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
  • immunohistochemistry; human; 1:100; loading ...; fig 1a
Santa Cruz Biotechnology ER antibody (Santa Cruz, SC-543) was used in immunohistochemistry on human samples at 1:100 (fig 1a). Sci Rep (2016) ncbi
mouse monoclonal (F-10)
  • western blot; human; loading ...; fig 3b
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (F-10)
  • western blot; human; fig 2
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples (fig 2). PLoS ONE (2016) ncbi
  • immunoprecipitation; African green monkey; loading ...; fig 3
  • western blot; human; loading ...; fig 1c
In order to propose that HIF-2-alpha is a negative regulator of estrogen receptor expression in breast cancer, Santa Cruz Biotechnology ER antibody (Santa Cruz, HC-20) was used in immunoprecipitation on African green monkey samples (fig 3) and in western blot on human samples (fig 1c). FEBS Lett (2016) ncbi
mouse monoclonal (F-10)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). Oncol Lett (2016) ncbi
  • immunohistochemistry; rat; 1:700; loading ...; fig 1f
In order to elucidate RAS-mediated signaling induced by estradiol treatment, Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-543) was used in immunohistochemistry on rat samples at 1:700 (fig 1f). Neuropsychopharmacology (2016) ncbi
mouse monoclonal (F-10)
  • western blot; human; fig 1
Santa Cruz Biotechnology ER antibody (santa Cruz, sc-8002) was used in western blot on human samples (fig 1). Breast Cancer Res (2016) ncbi
mouse monoclonal (F-10)
  • western blot; human; 1:750; fig 1
In order to characterize androgen receptor-targeted and vitamin D therapy for triple-negative breast cancer, Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples at 1:750 (fig 1). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (F-10)
  • chromatin immunoprecipitation; human; fig 3
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, sc-8002X) was used in chromatin immunoprecipitation on human samples (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (C-311)
  • western blot; mouse; 1:1000; fig 7
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc787) was used in western blot on mouse samples at 1:1000 (fig 7). Sci Rep (2016) ncbi
rat monoclonal (H226)
  • immunohistochemistry - paraffin section; baboons; fig 4
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-53493) was used in immunohistochemistry - paraffin section on baboons samples (fig 4). Oncotarget (2016) ncbi
mouse monoclonal (F-10)
  • western blot knockout validation; human; fig 1
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot knockout validation on human samples (fig 1). PLoS ONE (2016) ncbi
  • ChIP-Seq; human; fig 2a
  • chromatin immunoprecipitation; human; loading ...; fig 3b
In order to study aromatase inhibitor therapy in breast cancer, Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-543) was used in ChIP-Seq on human samples (fig 2a) and in chromatin immunoprecipitation on human samples (fig 3b). Clin Cancer Res (2016) ncbi
mouse monoclonal (D-12)
  • western blot; human; 1:1000; fig 6
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8005) was used in western blot on human samples at 1:1000 (fig 6). Breast Cancer Res (2016) ncbi
  • western blot; human; loading ...; fig 3b
Santa Cruz Biotechnology ER antibody (Santa Cruz, SC543) was used in western blot on human samples (fig 3b). Oncotarget (2015) ncbi
mouse monoclonal (D-12)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 5
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc8005) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 5). Oncogene (2016) ncbi
mouse monoclonal (F-10)
  • western blot; human; 1:200; fig 2
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples at 1:200 (fig 2). J Immunol Res (2015) ncbi
mouse monoclonal (F-10)
  • immunocytochemistry; human; loading ...; fig 3d
  • western blot; human; loading ...; fig 3c
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in immunocytochemistry on human samples (fig 3d) and in western blot on human samples (fig 3c). Oncogene (2016) ncbi
mouse monoclonal (D-12)
  • chromatin immunoprecipitation; human; fig 4
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8005X) was used in chromatin immunoprecipitation on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (D-12)
  • western blot; human; fig 1
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8005) was used in western blot on human samples (fig 1). Front Endocrinol (Lausanne) (2015) ncbi
mouse monoclonal (D-12)
  • western blot; mouse; 1:300
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8005) was used in western blot on mouse samples at 1:300. Reprod Sci (2016) ncbi
mouse monoclonal (D-12)
  • western blot; human; loading ...; fig 2b, s1c
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, ESR1) was used in western blot on human samples (fig 2b, s1c). Endocr Relat Cancer (2015) ncbi
mouse monoclonal (F-10)
  • western blot; human; fig 3
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (D-12)
  • western blot; human
In order to study signaling events downstream to the G-protein-coupled estrogen receptor activated by dehydroepiandrosterone, Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, sc-8005) was used in western blot on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (F-10)
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples (fig 1a). Oncotarget (2015) ncbi
mouse monoclonal (F-10)
  • western blot; human; 1:1000; fig 4
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002 F-10) was used in western blot on human samples at 1:1000 (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (2Q418)
  • chromatin immunoprecipitation; human; fig 5
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, 2Q418) was used in chromatin immunoprecipitation on human samples (fig 5). Biochim Biophys Acta (2015) ncbi
mouse monoclonal (D-12)
  • western blot; human; 1:1000; loading ...; fig 1f
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, sc-8005) was used in western blot on human samples at 1:1000 (fig 1f). Int J Oncol (2015) ncbi
mouse monoclonal (F-10)
  • western blot; human; loading ...; fig s2b
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples (fig s2b). Environ Health Perspect (2015) ncbi
mouse monoclonal (D-12)
  • western blot; human
In order to evaluate the role of leptin/STAT3 and HER2 receptor in tamoxifen resistance, Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8005) was used in western blot on human samples . Cell Oncol (Dordr) (2015) ncbi
mouse monoclonal (F-10)
  • western blot; mouse; fig 6
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, sc-8002) was used in western blot on mouse samples (fig 6). elife (2014) ncbi
mouse monoclonal (2Q418)
  • western blot; human; 1:500; fig 3
Santa Cruz Biotechnology ER antibody (Santa Cruz Biotechnology, sc-71064) was used in western blot on human samples at 1:500 (fig 3). Mol Autism (2014) ncbi
mouse monoclonal (F-10)
  • western blot; human; 1:200
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples at 1:200. Cell Oncol (Dordr) (2014) ncbi
mouse monoclonal (F-10)
  • western blot; mouse
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002X) was used in western blot on mouse samples . J Immunol (2014) ncbi
  • western blot; human; loading ...; fig 4f
Santa Cruz Biotechnology ER antibody (Santa Cruz, HC-20) was used in western blot on human samples (fig 4f). Mol Endocrinol (2014) ncbi
mouse monoclonal (D-12)
  • immunohistochemistry - paraffin section; human; 1:75
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8005) was used in immunohistochemistry - paraffin section on human samples at 1:75. Int J Cancer (2014) ncbi
  • western blot; human; loading ...; fig 2c
Santa Cruz Biotechnology ER antibody (Santa Cruz, HC-20) was used in western blot on human samples (fig 2c). J Biol Chem (2014) ncbi
mouse monoclonal (F-10)
  • western blot; human
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples . Nucleic Acids Res (2014) ncbi
mouse monoclonal (D-12)
  • western blot; human; fig 4
In order to elucidate the role of Snail in the epithelial to mesenchymal transition, Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8005) was used in western blot on human samples (fig 4). Mol Endocrinol (2007) ncbi
mouse monoclonal (F-10)
  • western blot; human; 1:400; fig 6
Santa Cruz Biotechnology ER antibody (Santa Cruz, sc-8002) was used in western blot on human samples at 1:400 (fig 6). Oncogene (2005) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 2
Abcam ER antibody (Abcam, ab3575) was used in immunohistochemistry on mouse samples (fig 2). Am J Cancer Res (2021) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 1c
Abcam ER antibody (Abcam, ab16660) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 1c). Nat Commun (2021) ncbi
domestic rabbit monoclonal (E115)
  • western blot; mouse; fig 1
  • western blot; human; loading ...; fig 1
Abcam ER antibody (abcam, ab32063) was used in western blot on mouse samples (fig 1) and in western blot on human samples (fig 1). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (ESR1/3557)
  • immunocytochemistry; human; 1:200; loading ...; fig s3a
Abcam ER antibody (abcam, ab259427) was used in immunocytochemistry on human samples at 1:200 (fig s3a). Stem Cell Res Ther (2021) ncbi
domestic rabbit monoclonal (E115)
  • immunocytochemistry; human; loading ...; fig s9a
Abcam ER antibody (Abcam, ab32063) was used in immunocytochemistry on human samples (fig s9a). Science (2020) ncbi
domestic rabbit monoclonal (E115)
  • immunohistochemistry; mouse; loading ...
Abcam ER antibody (Abcam, ab32063) was used in immunohistochemistry on mouse samples . Stem Cell Res Ther (2019) ncbi
domestic rabbit monoclonal (E115)
  • immunohistochemistry; rat; 1:200; loading ...; fig 4a
  • western blot; rat; 1:1000; loading ...; fig 6a
Abcam ER antibody (Abcam, ab32063) was used in immunohistochemistry on rat samples at 1:200 (fig 4a) and in western blot on rat samples at 1:1000 (fig 6a). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (EPR4097)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6a
Abcam ER antibody (Abcam, ab108398) was used in immunohistochemistry - paraffin section on mouse samples (fig 6a). Cell Rep (2019) ncbi
domestic rabbit monoclonal (E91)
  • western blot; human; 1:1000; loading ...; fig 1a
Abcam ER antibody (Abcam, ab32396) was used in western blot on human samples at 1:1000 (fig 1a). Mol Cell Biol (2019) ncbi
domestic rabbit monoclonal (E115)
  • western blot; mouse; 1:1000; loading ...; fig 6a
Abcam ER antibody (Abcam, ab32063) was used in western blot on mouse samples at 1:1000 (fig 6a). Nat Commun (2018) ncbi
domestic rabbit monoclonal (E91)
  • other; human; loading ...; fig 4c
Abcam ER antibody (Abcam, ab32396) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (E115)
  • chromatin immunoprecipitation; mouse; fig 2f
Abcam ER antibody (Abcam, ab32063) was used in chromatin immunoprecipitation on mouse samples (fig 2f). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit monoclonal (E91)
  • western blot; human; loading ...; fig 1d
In order to identify a positive feedback loop where the cell cycle regulatory factor Spy1 activates ERK1/2 in a MEK-independent fashion, Abcam ER antibody (Abcam, ab32396) was used in western blot on human samples (fig 1d). Oncotarget (2017) ncbi
domestic rabbit monoclonal (E115)
  • western blot; rat; 1:1000; loading ...; fig 5b
Abcam ER antibody (Abcam, ab32063) was used in western blot on rat samples at 1:1000 (fig 5b). Toxins (Basel) (2017) ncbi
domestic rabbit monoclonal (E115)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...; fig 5a
In order to determine the incidence of adenomyosis and the expression of estrogen receptors in uterus of mice exposed to TCDD., Abcam ER antibody (Abcam, ab32063) was used in immunohistochemistry - paraffin section on mouse samples at 1:150 (fig 5a). Biol Reprod (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 5s
Abcam ER antibody (Abcam, 16660) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5s). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; fig 1
  • western blot; mouse; 1:500; fig 1
Abcam ER antibody (Abcam, ab75635) was used in immunohistochemistry on mouse samples at 1:100 (fig 1) and in western blot on mouse samples at 1:500 (fig 1). Sci Rep (2016) ncbi
domestic rabbit monoclonal (E115)
  • chromatin immunoprecipitation; human; fig 3e
  • western blot; human; fig 2a
In order to determine how estrogen enhances motility and cell viability of breast cancer cells through the Eralpha-deltaNp63-Integrin Beta 4 signaling pathway, Abcam ER antibody (Abcam, ab32063) was used in chromatin immunoprecipitation on human samples (fig 3e) and in western blot on human samples (fig 2a). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human; fig 4
In order to study the role of MAPK-microRNA in the interaction between cancer cells and neighboring fibroblasts, Abcam ER antibody (abcam, ab16660) was used in western blot on human samples (fig 4). Cancer Biol Ther (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • immunocytochemistry; human; 1:100
Abcam ER antibody (Abcam, ab16660) was used in immunocytochemistry on human samples at 1:100. Front Cell Dev Biol (2015) ncbi
domestic rabbit monoclonal (Sp1)
  • western blot; human
Abcam ER antibody (Abcam, SP-1) was used in western blot on human samples . Breast Cancer Res (2014) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry - paraffin section; human
Abcam ER antibody (Abcam, ab16660) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (E115)
  • western blot; mouse; 1:1000
Abcam ER antibody (Abcam, Ab32063) was used in western blot on mouse samples at 1:1000. Neuroscience (2014) ncbi
Bio-Rad
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; cat; loading ...; fig 1a
Bio-Rad ER antibody (AbD Serotec, 6F11) was used in immunohistochemistry - paraffin section on cat samples (fig 1a). Sci Rep (2020) ncbi
Active Motif
mouse monoclonal (F3)
  • chromatin immunoprecipitation; human; fig 6
In order to analyze tamoxifen-resistance in ERalpha-positive breast cancer by degradation of NCoR due to COPS5 amplification and overexpression, Active Motif ER antibody (Active Motif, 61035) was used in chromatin immunoprecipitation on human samples (fig 6). Nat Commun (2016) ncbi
mouse monoclonal (F3)
  • immunoprecipitation; human
  • western blot; human; 1:500
Active Motif ER antibody (Active Motif, 61035) was used in immunoprecipitation on human samples and in western blot on human samples at 1:500. Lupus (2013) ncbi
Cell Signaling Technology
mouse monoclonal (16J4)
  • western blot; human; 1:1000; loading ...; fig s4b
Cell Signaling Technology ER antibody (CST, 2511S) was used in western blot on human samples at 1:1000 (fig s4b). Cell Death Discov (2022) ncbi
domestic rabbit monoclonal (D8H8)
  • chromatin immunoprecipitation; human; 1:200; loading ...; fig 3b
  • western blot; human; loading ...
Cell Signaling Technology ER antibody (Cell signaling Technology, 8644) was used in chromatin immunoprecipitation on human samples at 1:200 (fig 3b) and in western blot on human samples . Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology ER antibody (Cell Signaling Technology, 8644) was used in western blot on human samples (fig 3a). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human; 1:1000; loading ...; fig 1a, 2c, 3e, 7g
Cell Signaling Technology ER antibody (Cell Signaling, 8644) was used in western blot on human samples at 1:1000 (fig 1a, 2c, 3e, 7g). Theranostics (2020) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology ER antibody (CST, 8644) was used in western blot on human samples (fig 1a). Cell Commun Signal (2019) ncbi
mouse monoclonal (16J4)
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology ER antibody (Cell Signaling, 2511) was used in western blot on human samples (fig 7b). Cell (2019) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human; loading ...; fig s2
Cell Signaling Technology ER antibody (Cell Signaling, 8644) was used in western blot on human samples (fig s2). Breast Cancer Res (2019) ncbi
mouse monoclonal (16J4)
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology ER antibody (Cell Signaling, 2511) was used in western blot on human samples at 1:1000 (fig 1a). Mol Cell Biol (2019) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human; loading ...; fig 4a
In order to study the interaction between UXT and LOX-PP, Cell Signaling Technology ER antibody (Cell Signaling, 8644) was used in western blot on human samples (fig 4a). J Cell Biochem (2017) ncbi
domestic rabbit monoclonal (D8H8)
  • immunoprecipitation; human; loading ...; fig ED8g
  • western blot; human; 1:500; loading ...; fig 2c, 4b, 4e,ED4b
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., Cell Signaling Technology ER antibody (Cell Signaling, 8644) was used in immunoprecipitation on human samples (fig ED8g) and in western blot on human samples at 1:500 (fig 2c, 4b, 4e,ED4b). Nature (2017) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human; 1:1000; loading ...; fig 4C
Cell Signaling Technology ER antibody (Cell Signaling, 8644) was used in western blot on human samples at 1:1000 (fig 4C). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D1A3)
  • western blot; human; 1:500; loading ...; fig 4e
Cell Signaling Technology ER antibody (Cell Signalling, 5587) was used in western blot on human samples at 1:500 (fig 4e). Oncogene (2017) ncbi
mouse monoclonal (16J4)
  • western blot; human; 1:500; loading ...; fig 4e
Cell Signaling Technology ER antibody (Cell Signalling, 2511) was used in western blot on human samples at 1:500 (fig 4e). Oncogene (2017) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human; loading ...; fig 2g
In order to show that that MSI2 directly regulates estrogen receptor 1 in breast cancer cells, Cell Signaling Technology ER antibody (Cell signaling, 8644) was used in western blot on human samples (fig 2g). Oncogene (2017) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human; 1:1000; tbl s6
Cell Signaling Technology ER antibody (Cell Signaling, 8644) was used in western blot on human samples at 1:1000 (tbl s6). PLoS Genet (2016) ncbi
mouse monoclonal (16J4)
  • western blot; human; fig S1a
Cell Signaling Technology ER antibody (Cell Signalling, 2511) was used in western blot on human samples (fig S1a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D1A3)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology ER antibody (Cell Signaling Technology, 5587P) was used in western blot on human samples (fig 4b). Oncotarget (2016) ncbi
mouse monoclonal (16J4)
  • flow cytometry; bovine; 1:50; fig 6
In order to study bovine mammary epithelial cells during staphylococcus aureus internalization and the antimicrobial and anti-inflammatory effects of estradiol, Cell Signaling Technology ER antibody (Cell Signaling Technology, 2511S) was used in flow cytometry on bovine samples at 1:50 (fig 6). Mediators Inflamm (2016) ncbi
mouse monoclonal (16J4)
  • immunohistochemistry - paraffin section; human; 1:50; fig s1
In order to utilize ovarian cancer xenograft models to study dynamic modulation of phosphoprotein expression, Cell Signaling Technology ER antibody (Cell Signaling, 2511) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig s1). BMC Cancer (2016) ncbi
mouse monoclonal (16J4)
  • western blot; human; fig 4
Cell Signaling Technology ER antibody (Cell Signaling, 2511S) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology ER antibody (Cell Signaling, 2517S) was used in western blot on human samples (fig 5). Oncogene (2016) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; rat; 1:500; fig s2
Cell Signaling Technology ER antibody (Cell Signaling Technology, 8644) was used in western blot on rat samples at 1:500 (fig s2). Life Sci (2015) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human; fig 1
Cell Signaling Technology ER antibody (Cell Signal, D8H8) was used in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human
Cell Signaling Technology ER antibody (Cell Signaling Technology, 8644) was used in western blot on human samples . Cell Death Dis (2014) ncbi
domestic rabbit monoclonal (D8H8)
  • western blot; human
Cell Signaling Technology ER antibody (Cell Signaling Technology, D8H8) was used in western blot on human samples . Cell Biochem Biophys (2015) ncbi
mouse monoclonal (16J4)
  • western blot; human
Cell Signaling Technology ER antibody (Cell Signaling, 2511) was used in western blot on human samples . Oncogene (2014) ncbi
Ventana
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:250; loading ...
Ventana ER antibody (Ventana, SP1) was used in immunohistochemistry on human samples at 1:250. Mod Pathol (2020) ncbi
domestic rabbit monoclonal (Sp1)
  • immunohistochemistry; human; 1:50; loading ...; fig 3b
Ventana ER antibody (Ventana, 790-4324) was used in immunohistochemistry on human samples at 1:50 (fig 3b). Oncogene (2018) ncbi
Vector Laboratories
  • immunohistochemistry - paraffin section; mouse; fig 3
Vector Laboratories ER antibody (Vector Laboratories, VP-E613) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). Proc Natl Acad Sci U S A (2016) ncbi
  • immunohistochemistry - paraffin section; human; 1:200
Vector Laboratories ER antibody (Vector Laboratories, VP-E613) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cell Res (2014) ncbi
Leica Biosystems
mouse monoclonal
  • immunohistochemistry; human; 1:50; fig 7a
Leica Biosystems ER antibody (Leica Biosystems, NCL-L-ER-6F11) was used in immunohistochemistry on human samples at 1:50 (fig 7a). Biomedicines (2021) ncbi
mouse monoclonal
  • immunohistochemistry; human; 1:50; fig 2g
Leica Biosystems ER antibody (Novocastra, NCL-L-ER-6F11) was used in immunohistochemistry on human samples at 1:50 (fig 2g). Nat Commun (2018) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 6e
Leica Biosystems ER antibody (Novocastra, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 6e). J Pathol (2017) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 3
Leica Biosystems ER antibody (Novocastra, Leica Biosystem, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Taiwan J Obstet Gynecol (2016) ncbi
monoclonal (6F11)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 1
In order to investigate the contribution of PI3K/AKT pathway to the development of radiation carcinogenesis, Leica Biosystems ER antibody (Leica Microsystems, 6F11) was used in immunohistochemistry - paraffin section on rat samples (fig 1). J Radiat Res (2017) ncbi
mouse monoclonal (6F11)
  • western blot; human; loading ...; fig s6
Leica Biosystems ER antibody (Leica Biosystems, 6 F11) was used in western blot on human samples (fig s6). Breast Cancer Res (2016) ncbi
monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 1
  • immunocytochemistry; human; loading ...; fig S2G
Leica Biosystems ER antibody (Leica, 6F11) was used in immunohistochemistry - paraffin section on human samples (tbl 1) and in immunocytochemistry on human samples (fig S2G). Oncotarget (2016) ncbi
monoclonal (6F11)
  • immunohistochemistry; human; loading ...
In order to report the clinicopathological features and prognostic factors of pregnancy-associated gastric cancer, Leica Biosystems ER antibody (Novocastra, 6F11) was used in immunohistochemistry on human samples . Gut Liver (2016) ncbi
monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; 1:35; loading ...; tbl 2
In order to present the clinicopathological features of nine cases of renal cell carcinoma metastatic to the ovary or the fallopian tube, Leica Biosystems ER antibody (Leica Biosystems, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:35 (tbl 2). Hum Pathol (2016) ncbi
monoclonal (6F11)
  • immunohistochemistry; human; 1:35; tbl 2
In order to characterize eleven cases of primary glial and neuronal tumors of the ovary or peritoneum, Leica Biosystems ER antibody (Leica Microsystems, 6F11) was used in immunohistochemistry on human samples at 1:35 (tbl 2). Am J Surg Pathol (2016) ncbi
mouse monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; tbl s5
In order to explore the relationship between hnRNP A1 and RON tumoral expression, Leica Biosystems ER antibody (Novocastra, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl s5). Oncotarget (2016) ncbi
mouse monoclonal
  • western blot; human; fig 3c
In order to study aromatase inhibitor therapy in breast cancer, Leica Biosystems ER antibody (Leica Biosystems, NCL-L-ER-6F11) was used in western blot on human samples (fig 3c). Clin Cancer Res (2016) ncbi
monoclonal (6F11)
  • western blot; human; 1:500; fig 4d
In order to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture, Leica Biosystems ER antibody (Novocastra, NCL-ER-6F11/2) was used in western blot on human samples at 1:500 (fig 4d). Nat Commun (2015) ncbi
monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; 1:70; fig 1b
In order to study markers of the epithelial to mesenchymal transition using invasive lobular carcinoma samples, Leica Biosystems ER antibody (Novocastra, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:70 (fig 1b). J Pathol (2016) ncbi
mouse monoclonal
  • immunohistochemistry; human; 1:50
Leica Biosystems ER antibody (Leica Biosystems, 6F11) was used in immunohistochemistry on human samples at 1:50. Hum Pathol (2015) ncbi
monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; loading ...
In order to develop a non-cross-reactive multiplex to measure 8 common breast cancer biomarkers, Leica Biosystems ER antibody (Leica, 6F11) was used in immunohistochemistry - paraffin section on human samples . Appl Immunohistochem Mol Morphol (2016) ncbi
mouse monoclonal
  • immunohistochemistry; human; 1:400
In order to evaluate the potential protein markers of bone metastases in breast cancer patients, Leica Biosystems ER antibody (Novocastra, NCL-L-ER-6F11) was used in immunohistochemistry on human samples at 1:400. Pathol Oncol Res (2015) ncbi
mouse monoclonal
  • immunohistochemistry; human; 1:200
Leica Biosystems ER antibody (Leica Microsystems, 6 F11) was used in immunohistochemistry on human samples at 1:200. J Ovarian Res (2015) ncbi
monoclonal (6F11)
  • immunohistochemistry - paraffin section; human; 1:50
Leica Biosystems ER antibody (Novocastra Lab, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:50. Hum Pathol (2015) ncbi
monoclonal (6F11)
  • immunohistochemistry - paraffin section; cat; 1:40
Leica Biosystems ER antibody (Novocastra, 6F11) was used in immunohistochemistry - paraffin section on cat samples at 1:40. J Comp Pathol (2015) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; rat
In order to study the effect of Pomegranate Fruit Extract (PFE) in a testosterone-induced benign prostatic hyperplasia model, Leica Biosystems ER antibody (Novacastra, NCL-L-ER-6F11) was used in immunohistochemistry - paraffin section on rat samples . Prostate (2015) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human
Leica Biosystems ER antibody (Novocastra, NCL-L-ER-6F11) was used in immunohistochemistry - paraffin section on human samples . BMC Cancer (2014) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human
Leica Biosystems ER antibody (Germany Leica, 6F11) was used in immunohistochemistry - paraffin section on human samples . Cell Biochem Biophys (2015) ncbi
monoclonal (6F11)
  • immunohistochemistry - frozen section; human; 1:100
Leica Biosystems ER antibody (Leica Microsystems, 6F11) was used in immunohistochemistry - frozen section on human samples at 1:100. Hum Reprod (2014) ncbi
monoclonal
  • immunohistochemistry; human
Leica Biosystems ER antibody (Novocastra, RTU-ER-6F11) was used in immunohistochemistry on human samples . Endocr Relat Cancer (2014) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:35
Leica Biosystems ER antibody (Novocastra, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:35. Hum Pathol (2014) ncbi
monoclonal (6F11)
  • immunohistochemistry; human
In order to measure protein expression of insulin-like growth factor receptor pathway members and evaluate their prognostic significance across the different early breast cancer subtypes, Leica Biosystems ER antibody (Novocastra, 6F11) was used in immunohistochemistry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:200
Leica Biosystems ER antibody (Leica Microsystems, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:200. Virchows Arch (2014) ncbi
mouse monoclonal
  • immunohistochemistry; human
Leica Biosystems ER antibody (Novocastra, 6F11) was used in immunohistochemistry on human samples . Breast Cancer Res Treat (2014) ncbi
mouse monoclonal
  • immunohistochemistry; human; 1:200
Leica Biosystems ER antibody (Novocastra, 6F11) was used in immunohistochemistry on human samples at 1:200. Horm Cancer (2014) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human
In order to identify the origin of ovarian Brenner tumour, Leica Biosystems ER antibody (Leica Microsystems, RTU-ER-6F11) was used in immunohistochemistry - paraffin section on human samples . Eur J Cancer (2013) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:300
Leica Biosystems ER antibody (Novocastra, 6F11) was used in immunohistochemistry - paraffin section on human samples at 1:300. Korean J Pathol (2013) ncbi
Articles Reviewed
  1. Mukherjee B, Tiwari A, Palo A, Pattnaik N, Samantara S, Dixit M. Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF. Cell Death Discov. 2022;8:442 pubmed publisher
  2. Aboouf M, Armbruster J, Thiersch M, Guscetti F, Kristiansen G, Schraml P, et al. Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer Cells. Int J Mol Sci. 2022;23: pubmed publisher
  3. Liu X, Viswanadhapalli S, Kumar S, Lee T, Moore A, Ma S, et al. Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress. Nat Cancer. 2022;: pubmed publisher
  4. Li X, Zhuo S, Zhuang T, Cho Y, Wu G, Liu Y, et al. YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis. Nat Commun. 2022;13:3075 pubmed publisher
  5. Due S, Watson D, Bastian I, Eichelmann A, Hussey D. Oestrogen Receptor Isoforms May Represent a Therapeutic Target in Oesophageal Adenocarcinoma. Cancers (Basel). 2022;14: pubmed publisher
  6. Hsu C, Hsu L, Hsueh Y, Lin C, Chang H, Hsu C. Ovarian Folliculogenesis and Uterine Endometrial Receptivity after Intermittent Vaginal Injection of Recombinant Human Follicle-Stimulating Hormone in Infertile Women Receiving In Vitro Fertilization and in Immature Female Rats. Int J Mol Sci. 2021;22: pubmed publisher
  7. Nittoli V, Colella M, Porciello A, Reale C, Roberto L, Russo F, et al. Multi Species Analyses Reveal Testicular T3 Metabolism and Signalling as a Target of Environmental Pesticides. Cells. 2021;10: pubmed publisher
  8. Aleksandrovych V, Wrona A, Bereza T, Pitynski K, Gil K. Oviductal Telocytes in Patients with Uterine Myoma. Biomedicines. 2021;9: pubmed publisher
  9. Moon S, Lee H, Kim S, Hong J, Chun S, Lee H, et al. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells. BMC Cancer. 2021;21:931 pubmed publisher
  10. Noreldin A, Gewaily M, Saadeldin I, Abomughaid M, Khafaga A, Elewa Y. Osteoblast-activating peptide exhibits a specific distribution pattern in mouse ovary and may regulate ovarian steroids and local calcium levels. Am J Transl Res. 2021;13:5796-5814 pubmed
  11. Prekovic S, Schuurman K, Mayayo Peralta I, Manjón A, Buijs M, Yavuz S, et al. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nat Commun. 2021;12:4360 pubmed publisher
  12. Sribenja S, Maguire O, Attwood K, Buas M, Palmer J, Ambrosone C, et al. Deletion of Foxa1 in the mouse mammary gland results in abnormal accumulation of luminal progenitor cells: a link between reproductive factors and ER-/TNBC breast cancer?. Am J Cancer Res. 2021;11:3263-3270 pubmed
  13. Mu X, Tu Z, Chen X, Hong Y, Geng Y, Zhang Y, et al. In utero Exposure to Excessive Estrogen Impairs Homologous Recombination and Oogenesis via Estrogen Receptor 2 in Mice. Front Cell Dev Biol. 2021;9:669732 pubmed publisher
  14. Servetto A, Kollipara R, Formisano L, Lin C, Lee K, Sudhan D, et al. Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer. Clin Cancer Res. 2021;27:4379-4396 pubmed publisher
  15. Tsoi H, Man E, Chau K, Khoo U. Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer. Cancers (Basel). 2021;13: pubmed publisher
  16. Xia X, Huang C, Liao Y, Liu Y, He J, Shao Z, et al. The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression. Cell Death Dis. 2021;12:329 pubmed publisher
  17. Zhang Z, Park J, Ahn I, Diamante G, Sivakumar N, Arneson D, et al. Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice. elife. 2021;10: pubmed publisher
  18. Li W, Gu X, Liu C, Shi Y, Wang P, Zhang N, et al. A synergetic effect of BARD1 mutations on tumorigenesis. Nat Commun. 2021;12:1243 pubmed publisher
  19. Wan X, Hou J, Liu S, Zhang Y, Li W, Zhang Y, et al. Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer Cells by Regulating E-Cadherin. Front Cell Dev Biol. 2021;9:583572 pubmed publisher
  20. Yokomizo R, Fujiki Y, Kishigami H, Kishi H, Kiyono T, Nakayama S, et al. Endometrial regeneration with endometrial epithelium: homologous orchestration with endometrial stroma as a feeder. Stem Cell Res Ther. 2021;12:130 pubmed publisher
  21. Christgen M, Bartels S, van Luttikhuizen J, Bublitz J, Rieger L, Christgen H, et al. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements. Mod Pathol. 2020;33:2483-2498 pubmed publisher
  22. Klein I, Boija A, Afeyan L, Hawken S, Fan M, Dall Agnese A, et al. Partitioning of cancer therapeutics in nuclear condensates. Science. 2020;368:1386-1392 pubmed publisher
  23. Kim M, Chung Y, Kim H, Woo J, Ahn S, Park S. Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast. Breast Cancer Res. 2020;22:32 pubmed publisher
  24. Chen X, Wang K, Guo W, Li L, Yu P, Sun X, et al. UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics. 2020;10:1833-1848 pubmed publisher
  25. Kluz P, Kolb R, Xie Q, Borcherding N, Liu Q, Luo Y, et al. Cancer cell-intrinsic function of CD177 in attenuating β-catenin signaling. Oncogene. 2020;39:2877-2889 pubmed publisher
  26. Granados Soler J, Bornemann Kolatzki K, Beck J, Brenig B, Schütz E, Betz D, et al. Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival. Sci Rep. 2020;10:1003 pubmed publisher
  27. Dagher E, Royer V, Buchet P, Abadie J, Loussouarn D, Campone M, et al. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer. BMC Cancer. 2019;19:1267 pubmed publisher
  28. Lee Y, Ho S, Graves J, Xiao Y, Huang S, Lin W. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer. Breast Cancer Res. 2019;21:134 pubmed publisher
  29. Davaadelger B, Choi M, Singhal H, Clare S, Khan S, Kim J. BRCA1 mutation influences progesterone response in human benign mammary organoids. Breast Cancer Res. 2019;21:124 pubmed publisher
  30. Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  31. Li B, Zhang Q, Sun J, Lai D. Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model. Stem Cell Res Ther. 2019;10:257 pubmed publisher
  32. Guan J, Zhou W, Hafner M, Blake R, Chalouni C, Chen I, et al. Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility. Cell. 2019;178:949-963.e18 pubmed publisher
  33. Zheng H, Zhao Y, Xu Y, Zhang Z, Zhu J, Fan Y, et al. Long-time qingyan formula extract treatment exerts estrogenic activities on reproductive tissues without side effects in ovariectomized rats and via active ER to ERE-independent gene regulation. Aging (Albany NY). 2019;11:4032-4049 pubmed publisher
  34. Yin M, Zhou H, Lin C, Long L, Yang X, Zhang H, et al. CD34+KLF4+ Stromal Stem Cells Contribute to Endometrial Regeneration and Repair. Cell Rep. 2019;27:2709-2724.e3 pubmed publisher
  35. Kaya P, Lee S, Lee Y, Kwon S, Yang H, Lee H, et al. Curcumae Radix Extract Decreases Mammary Tumor-Derived Lung Metastasis via Suppression of C-C Chemokine Receptor Type 7 Expression. Nutrients. 2019;11: pubmed publisher
  36. Greer Y, Gilbert S, Gril B, Narwal R, Peacock Brooks D, Tice D, et al. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. Breast Cancer Res. 2019;21:27 pubmed publisher
  37. Nassa G, Salvati A, Tarallo R, Gigantino V, Alexandrova E, Memoli D, et al. Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells. Sci Adv. 2019;5:eaav5590 pubmed publisher
  38. Helzer K, Szatkowski Ozers M, Meyer M, Benkusky N, Solodin N, Reese R, et al. The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2. Mol Cell Biol. 2019;39: pubmed publisher
  39. Maani N, Sabha N, Rezai K, Ramani A, Groom L, Eltayeb N, et al. Tamoxifen therapy in a murine model of myotubular myopathy. Nat Commun. 2018;9:4849 pubmed publisher
  40. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  41. Poli V, Fagnocchi L, Fasciani A, Cherubini A, Mazzoleni S, Ferrillo S, et al. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state. Nat Commun. 2018;9:1024 pubmed publisher
  42. Browne A, Charmsaz S, Varešlija D, Fagan A, Cosgrove N, Cocchiglia S, et al. Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer. Oncogene. 2018;37:2008-2021 pubmed publisher
  43. Bostner J, Alayev A, Berman A, Fornander T, Nordenskjold B, Holz M, et al. Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2018;168:17-27 pubmed publisher
  44. Thaler S, Schmidt M, Roβwag S, Thiede G, Schad A, Sleeman J. Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells. Oncotarget. 2017;8:72281-72301 pubmed publisher
  45. Carvajal Hausdorf D, Mani N, Velcheti V, Schalper K, Rimm D. Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer. J Immunother Cancer. 2017;5:81 pubmed publisher
  46. Khanal T, Choi K, Leung Y, Wang J, Kim D, Janakiram V, et al. Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer. Sci Rep. 2017;7:10662 pubmed publisher
  47. Yosefzon Y, David C, Tsukerman A, Pnueli L, Qiao S, Boehm U, et al. An epigenetic switch repressing Tet1 in gonadotropes activates the reproductive axis. Proc Natl Acad Sci U S A. 2017;114:10131-10136 pubmed publisher
  48. Pasutto F, Zenkel M, Hoja U, Berner D, Uebe S, Ferrazzi F, et al. Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1. Nat Commun. 2017;8:15466 pubmed publisher
  49. Ferraiuolo R, Tubman J, Sinha I, Hamm C, Porter L. The cyclin-like protein, SPY1, regulates the ER? and ERK1/2 pathways promoting tamoxifen resistance. Oncotarget. 2017;8:23337-23352 pubmed publisher
  50. Toska E, Osmanbeyoglu H, Castel P, Chan C, Hendrickson R, Elkabets M, et al. PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D. Science. 2017;355:1324-1330 pubmed publisher
  51. Sinkala E, Sollier Christen E, Renier C, Rosàs Canyelles E, Che J, Heirich K, et al. Profiling protein expression in circulating tumour cells using microfluidic western blotting. Nat Commun. 2017;8:14622 pubmed publisher
  52. Gilligan L, Gondal A, Tang V, Hussain M, Arvaniti A, Hewitt A, et al. Estrone Sulfate Transport and Steroid Sulfatase Activity in Colorectal Cancer: Implications for Hormone Replacement Therapy. Front Pharmacol. 2017;8:103 pubmed publisher
  53. Hernández Aragón L, García Villamar V, Carrasco Ruiz M, Nicolás Toledo L, Ortega A, Cuevas Romero E, et al. Role of Estrogens in the Size of Neuronal Somata of Paravaginal Ganglia in Ovariectomized Rabbits. Biomed Res Int. 2017;2017:2089645 pubmed publisher
  54. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  55. Helle J, Keiler A, Zierau O, Dörfelt P, Vollmer G, Lehmann L, et al. Effects of the aryl hydrocarbon receptor agonist 3-methylcholanthrene on the 17?-estradiol regulated mRNA transcriptome of the rat uterus. J Steroid Biochem Mol Biol. 2017;171:133-143 pubmed publisher
  56. Teveroni E, Pellegrino M, Sacconi S, Calandra P, Cascino I, Farioli Vecchioli S, et al. Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity. J Clin Invest. 2017;127:1531-1545 pubmed publisher
  57. Wu D, Kimura F, Zheng L, Ishida M, Niwa Y, Hirata K, et al. Chronic endometritis modifies decidualization in human endometrial stromal cells. Reprod Biol Endocrinol. 2017;15:16 pubmed publisher
  58. Palma Vera S, Schoen J, Chen S. Periovulatory follicular fluid levels of estradiol trigger inflammatory and DNA damage responses in oviduct epithelial cells. PLoS ONE. 2017;12:e0172192 pubmed publisher
  59. Ibrahim M, Elwan W. Role of topical dehydroepiandrosterone in ameliorating isotretinoin-induced Meibomian gland dysfunction in adult male albino rat. Ann Anat. 2017;211:78-87 pubmed publisher
  60. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  61. McDermott M, Chumanevich A, Lim C, Liang J, Chen M, Altilia S, et al. Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer. Oncotarget. 2017;8:12558-12575 pubmed publisher
  62. Méndez López L, Zavala Pompa A, Cortés Gutiérrez E, Cerda Flores R, Dávila Rodríguez M. Leptin receptor expression during the progression of endometrial carcinoma is correlated with estrogen and progesterone receptors. Arch Med Sci. 2017;13:228-235 pubmed publisher
  63. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed publisher
  64. Sánchez Morgan N, Kirsch K, Trackman P, Sonenshein G. UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells. J Cell Biochem. 2017;118:2347-2356 pubmed publisher
  65. Hopkinson B, Klitgaard M, Petersen O, Villadsen R, Rønnov Jessen L, Kim J. Establishment of a normal-derived estrogen receptor-positive cell line comparable to the prevailing human breast cancer subtype. Oncotarget. 2017;8:10580-10593 pubmed publisher
  66. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  67. Gao X, Sun L, Zhang N, Li C, Zhang J, Xiao Z, et al. Gestational Zearalenone Exposure Causes Reproductive and Developmental Toxicity in Pregnant Rats and Female Offspring. Toxins (Basel). 2017;9: pubmed publisher
  68. Yu H, Jiang Y, Liu L, Shan W, Chu X, Yang Z, et al. Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer. Oncotarget. 2017;8:13099-13115 pubmed publisher
  69. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  70. Konings G, Reynaert N, Delvoux B, Verhamme F, Bracke K, Brusselle G, et al. Increased levels of enzymes involved in local estradiol synthesis in chronic obstructive pulmonary disease. Mol Cell Endocrinol. 2017;443:23-31 pubmed publisher
  71. Rahman S, Zorca C, Traboulsi T, Noutahi E, Krause M, Mader S, et al. Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription. Nucleic Acids Res. 2017;45:3017-3030 pubmed publisher
  72. Aiello A, Bacci L, Re A, Ripoli C, Pierconti F, Pinto F, et al. MALAT1 and HOTAIR Long Non-Coding RNAs Play Opposite Role in Estrogen-Mediated Transcriptional Regulation in Prostate Cancer Cells. Sci Rep. 2016;6:38414 pubmed publisher
  73. Brooks S, Dykes A, Schreurs B. A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus. J Alzheimers Dis. 2017;56:185-196 pubmed publisher
  74. Liao X, Li J, Dong X, Wang X, Xiang Y, Li H, et al. ER? inhibited myocardin-induced differentiation in uterine fibroids. Exp Cell Res. 2017;350:73-82 pubmed publisher
  75. Corda G, Sala G, Lattanzio R, Iezzi M, Sallese M, Fragassi G, et al. Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer. J Pathol. 2017;241:350-361 pubmed publisher
  76. Bonneterre J, Bosq J, Jamme P, Valent A, Gilles E, Zukiwski A, et al. Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort. ESMO Open. 2016;1:e000072 pubmed
  77. Cardoso R, Burns A, Moeller J, Skinner D, Padmanabhan V. Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS. Endocrinology. 2016;157:4641-4653 pubmed
  78. Tu S, Lin Y, Huang C, Yang P, Chang H, Chang C, et al. Protein phosphatase Mg2+/Mn2+ dependent 1F promotes smoking-induced breast cancer by inactivating phosphorylated-p53-induced signals. Oncotarget. 2016;7:77516-77531 pubmed publisher
  79. Loverro G, Resta L, Dellino M, Edoardo D, Cascarano M, Loverro M, et al. Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals. Taiwan J Obstet Gynecol. 2016;55:686-691 pubmed publisher
  80. Harrod A, Fulton J, Nguyen V, Periyasamy M, Ramos Garcia L, Lai C, et al. Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer. Oncogene. 2017;36:2286-2296 pubmed publisher
  81. Showler K, Nishimura M, Daino K, Imaoka T, Nishimura Y, Morioka T, et al. Analysis of genes involved in the PI3K/Akt pathway in radiation- and MNU-induced rat mammary carcinomas. J Radiat Res. 2017;58:183-194 pubmed publisher
  82. Moe Y, Kyi Tha Thu C, Tanaka T, Ito H, Yahashi S, Matsuda K, et al. A Sexually Dimorphic Area of the Dorsal Hypothalamus in Mice and Common Marmosets. Endocrinology. 2016;157:4817-4828 pubmed
  83. Svoronos N, Perales Puchalt A, Allegrezza M, Rutkowski M, Payne K, Tesone A, et al. Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells. Cancer Discov. 2017;7:72-85 pubmed publisher
  84. Nanbo A, Kachi K, Yoshiyama H, Ohba Y. Epstein-Barr virus exploits host endocytic machinery for cell-to-cell viral transmission rather than a virological synapse. J Gen Virol. 2016;97:2989-3006 pubmed publisher
  85. Sikora M, Jacobsen B, Levine K, Chen J, Davidson N, Lee A, et al. WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines. Breast Cancer Res. 2016;18:92 pubmed publisher
  86. Grindstad T, Skjefstad K, Andersen S, Ness N, Nordby Y, Al Saad S, et al. Estrogen receptors ? and ? and aromatase as independent predictors for prostate cancer outcome. Sci Rep. 2016;6:33114 pubmed publisher
  87. Nielsen T, Jensen M, Burugu S, Gao D, Jørgensen C, Balslev E, et al. High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial. Clin Cancer Res. 2017;23:946-953 pubmed publisher
  88. Kang M, Jeong K, Kim W, Lee H, Gong G, Suh N, et al. Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer. Oncogene. 2017;36:1745-1752 pubmed publisher
  89. Vardaki I, Ceder S, Rutishauser D, Baltatzis G, Foukakis T, Panaretakis T. Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes. Oncotarget. 2016;7:74966-74978 pubmed publisher
  90. Mair B, Konopka T, Kerzendorfer C, Sleiman K, Salic S, Serra V, et al. Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity. PLoS Genet. 2016;12:e1006279 pubmed publisher
  91. Bruner Tran K, Duleba A, Taylor H, Osteen K. Developmental Toxicant Exposure Is Associated with Transgenerational Adenomyosis in a Murine Model. Biol Reprod. 2016;95:73 pubmed publisher
  92. Di Franco S, Turdo A, Benfante A, Colorito M, Gaggianesi M, Apuzzo T, et al. ?Np63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis. Oncotarget. 2016;7:54157-54173 pubmed publisher
  93. Petrovic N, Davidovic R, Jovanovic Cupic S, Krajnovic M, Lukic S, Petrovic M, et al. Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels. Mol Diagn Ther. 2016;20:603-615 pubmed
  94. Dhamad A, Zhou Z, Zhou J, Du Y. Systematic Proteomic Identification of the Heat Shock Proteins (Hsp) that Interact with Estrogen Receptor Alpha (ER?) and Biochemical Characterization of the ER?-Hsp70 Interaction. PLoS ONE. 2016;11:e0160312 pubmed publisher
  95. Ladd B, Mazzola A, Bihani T, Lai Z, BRADFORD J, Collins M, et al. Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations. Oncotarget. 2016;7:54120-54136 pubmed publisher
  96. Shen P, Chen M, He M, Chen L, Song Y, Xiao P, et al. Inhibition of ER?/ERK/P62 cascades induces "autophagic switch" in the estrogen receptor-positive breast cancer cells exposed to gemcitabine. Oncotarget. 2016;7:48501-48516 pubmed publisher
  97. Lu R, Hu X, Zhou J, Sun J, Zhu A, Xu X, et al. COPS5 amplification and overexpression confers tamoxifen-resistance in ER?-positive breast cancer by degradation of NCoR. Nat Commun. 2016;7:12044 pubmed publisher
  98. Stock K, Estrada M, Vidic S, Gjerde K, Rudisch A, Santo V, et al. Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery. Sci Rep. 2016;6:28951 pubmed publisher
  99. Higashimura Y, Kitakaze T, Harada N, Inui H, Nakano Y, Yamaji R. pVHL-mediated degradation of HIF-2? regulates estrogen receptor ? expression in normoxic breast cancer cells. FEBS Lett. 2016;590:2690-9 pubmed publisher
  100. Trapé A, Liu S, Cortés A, Ueno N, Gonzalez Angulo A. Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel. J Cancer. 2016;7:947-56 pubmed publisher
  101. Calaf G, Abarca Quinones J. Ras protein expression as a marker for breast cancer. Oncol Lett. 2016;11:3637-3642 pubmed
  102. Wang W, Kantorovich S, Babayan A, Hou B, Gall C, Lynch G. Estrogen's Effects on Excitatory Synaptic Transmission Entail Integrin and TrkB Transactivation and Depend Upon ?1-integrin function. Neuropsychopharmacology. 2016;41:2723-32 pubmed publisher
  103. Lu B, Chen Q, Zhang X, Cheng L. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases. Diagn Pathol. 2016;11:46 pubmed publisher
  104. Ávila Rodriguez M, Garcia Segura L, Hidalgo Lanussa O, Baez E, Gonzalez J, Barreto G. Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression. Mol Cell Endocrinol. 2016;433:35-46 pubmed publisher
  105. Simigdala N, Gao Q, Pancholi S, Roberg Larsen H, Zvelebil M, Ribas R, et al. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer. Breast Cancer Res. 2016;18:58 pubmed publisher
  106. Nguyen A, Yoshida M, Goodarzi H, Tavazoie S. Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness. Nat Commun. 2016;7:11246 pubmed publisher
  107. Thakkar A, Wang B, Picon Ruiz M, Buchwald P, Ince T. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016;157:77-90 pubmed publisher
  108. Song M, Park Y, Song H, Park S, Ahn J, Choi K, et al. Prognosis of Pregnancy-Associated Gastric Cancer: An Age-, Sex-, and Stage-Matched Case-Control Study. Gut Liver. 2016;10:731-8 pubmed publisher
  109. Liang L, Huang H, Dadhania V, Zhang J, Zhang M, Liu J. Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases. Hum Pathol. 2016;51:96-102 pubmed publisher
  110. Garcia Cuellar M, Büttner C, Bartenhagen C, Dugas M, Slany R. Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes. Cell Rep. 2016;15:310-22 pubmed publisher
  111. Medina Estrada I, López Meza J, Ochoa Zarzosa A. Anti-Inflammatory and Antimicrobial Effects of Estradiol in Bovine Mammary Epithelial Cells during Staphylococcus aureus Internalization. Mediators Inflamm. 2016;2016:6120509 pubmed publisher
  112. Carbognin L, Sperduti I, Brunelli M, Marcolini L, Nortilli R, Pilotto S, et al. Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer. J Exp Clin Cancer Res. 2016;35:50 pubmed publisher
  113. Ali H, Stavik B, Myklebust C, Andersen E, Dahm A, Iversen N, et al. Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region. PLoS ONE. 2016;11:e0152114 pubmed publisher
  114. Al Harras M, Houssen M, Shaker M, Farag K, Farouk O, Monir R, et al. Polymorphisms of glutathione S-transferase ? 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility. Oncol Lett. 2016;11:2182-2188 pubmed
  115. Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian X, et al. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016;40:847-56 pubmed publisher
  116. Tran Q, Firkins R, Giles J, Francis S, Matnishian V, Tran P, et al. Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1. J Biol Chem. 2016;291:10805-23 pubmed publisher
  117. Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed publisher
  118. Zhao Y, Xu L, Qiao Z, Gao L, Ding S, Ying X, et al. YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α. Sci Rep. 2016;6:23025 pubmed publisher
  119. Matsumoto H, Thike A, Li H, Yeong J, Koo S, Dent R, et al. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Res Treat. 2016;156:237-47 pubmed publisher
  120. Alkner S, Bendahl P, Ehinger A, Lövgren K, Rydén L, Fernö M. Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer. PLoS ONE. 2016;11:e0150977 pubmed publisher
  121. Cammas A, Lacroix Triki M, Pierredon S, Le Bras M, Iacovoni J, Teulade Fichou M, et al. hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression. Oncotarget. 2016;7:16793-805 pubmed publisher
  122. Kim S, Kim E, Lee H, Kim M, Yoon J, Koo J, et al. Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?. Ann Surg Oncol. 2016;23:1860-6 pubmed publisher
  123. Soares M, Ribeiro R, Najmudin S, Gameiro A, Rodrigues R, Cardoso F, et al. Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status. Oncotarget. 2016;7:17314-26 pubmed publisher
  124. Nair H, Baker R, Owston M, Escalona R, Dick E, Vandeberg J, et al. An efficient model of human endometriosis by induced unopposed estrogenicity in baboons. Oncotarget. 2016;7:10857-69 pubmed publisher
  125. Ma Y, Guo H, Zhang L, Tao L, Yin A, Liu Z, et al. Estrogen replacement therapy-induced neuroprotection against brain ischemia-reperfusion injury involves the activation of astrocytes via estrogen receptor β. Sci Rep. 2016;6:21467 pubmed publisher
  126. Kavlashvili T, Jia Y, Dai D, Meng X, Thiel K, Leslie K, et al. Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer. PLoS ONE. 2016;11:e0148912 pubmed publisher
  127. Su R, Strug M, Jeong J, Miele L, Fazleabas A. Aberrant activation of canonical Notch1 signaling in the mouse uterus decreases progesterone receptor by hypermethylation and leads to infertility. Proc Natl Acad Sci U S A. 2016;113:2300-5 pubmed publisher
  128. Ho J, Chang F, Huang F, Liu J, Liu Y, Chen S, et al. Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway. PLoS ONE. 2016;11:e0148301 pubmed publisher
  129. Varešlija D, McBryan J, Fagan A, Redmond A, Hao Y, Sims A, et al. Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors. Clin Cancer Res. 2016;22:2765-77 pubmed publisher
  130. Piggin C, Roden D, Gallego Ortega D, Lee H, Oakes S, Ormandy C. ELF5 isoform expression is tissue-specific and significantly altered in cancer. Breast Cancer Res. 2016;18:4 pubmed publisher
  131. El Gendi S, Mostafa M. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma. Pathol Oncol Res. 2016;22:461-70 pubmed publisher
  132. Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed publisher
  133. Zhuang T, Zhu J, Li Z, Lorent J, Zhao C, Dahlman Wright K, et al. p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells. Oncotarget. 2015;6:43853-68 pubmed publisher
  134. Alayev A, Salamon R, Berger S, Schwartz N, Cuesta R, Snyder R, et al. mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation. Oncogene. 2016;35:3535-43 pubmed publisher
  135. González Morán M. Immunohistochemical localization of progesterone receptor isoforms and estrogen receptor alpha in the chicken oviduct magnum during development. Acta Histochem. 2015;117:681-7 pubmed publisher
  136. McCart Reed A, Kutasovic J, Vargas A, Jayanthan J, Al Murrani A, Reid L, et al. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol. 2016;238:489-94 pubmed publisher
  137. Wunsch E, Klak M, Wasik U, Milkiewicz M, Blatkiewicz M, Urasinska E, et al. Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR. J Immunol Res. 2015;2015:571353 pubmed publisher
  138. O Shaughnessy J, Campone M, Brain E, Neven P, Hayes D, Bondarenko I, et al. Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer. Ann Oncol. 2016;27:106-13 pubmed publisher
  139. Soares M, Correia J, Peleteiro M, Ferreira F. St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study. Tumour Biol. 2016;37:4053-64 pubmed publisher
  140. Radhika N, Govindaraj V, Sarangi S, Rao A. Neonatal exposure to 17β-estradiol down-regulates the expression of synaptogenesis related genes in selected brain regions of adult female rats. Life Sci. 2015;141:1-7 pubmed publisher
  141. Xue X, Yang Y, Zhang A, Fong K, Kim J, Song B, et al. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene. 2016;35:2746-55 pubmed publisher
  142. Jung Y, Kim H, Koo J. Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer. PLoS ONE. 2015;10:e0137204 pubmed publisher
  143. Coelho R, Calaça I, Celestrini D, Correia Carneiro A, Costa M, Zancan P, et al. Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma. Oncotarget. 2015;6:29375-87 pubmed publisher
  144. Gómez R, Ossa C, Montoya M, Echeverri C, Ángel G, Ascuntar J, et al. Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy. Ecancermedicalscience. 2015;9:562 pubmed publisher
  145. Slaats G, Saldivar J, Bacal J, Zeman M, Kile A, Hynes A, et al. DNA replication stress underlies renal phenotypes in CEP290-associated Joubert syndrome. J Clin Invest. 2015;125:3657-66 pubmed publisher
  146. Hsu P, Hsu H, Hsiao T, Ye Z, Wang E, Profit A, et al. Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells. Oncogene. 2016;35:2379-89 pubmed publisher
  147. Malaterre J, Pereira L, Putoczki T, Millen R, Paquet Fifield S, Germann M, et al. Intestinal-specific activatable Myb initiates colon tumorigenesis in mice. Oncogene. 2016;35:2475-84 pubmed publisher
  148. KapucuoÄŸlu N, Bozkurt K, BaÅŸpınar Å, Koçer M, EroÄŸlu H, Akdeniz R, et al. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Pathol Res Pract. 2015;211:740-7 pubmed publisher
  149. Adachi K, Miki Y, Saito R, Hata S, Yamauchi M, Mikami Y, et al. Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis. Hum Pathol. 2015;46:1685-93 pubmed publisher
  150. Zhang Y, Wei X, Liang Y, Chen W, Zhang F, Bai J, et al. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation. PLoS ONE. 2015;10:e0135851 pubmed publisher
  151. Wang D, Pang Z, Clarke G, Nofech Mozes S, Liu K, Cheung A, et al. Ki-67 Membranous Staining: Biologically Relevant or an Artifact of Multiplexed Immunofluorescent Staining. Appl Immunohistochem Mol Morphol. 2016;24:447-52 pubmed publisher
  152. Montt Guevara M, Giretti M, Russo E, Giannini A, Mannella P, Genazzani A, et al. Estetrol Modulates Endothelial Nitric Oxide Synthesis in Human Endothelial Cells. Front Endocrinol (Lausanne). 2015;6:111 pubmed publisher
  153. McBryan J, Fagan A, McCartan D, Bane F, Varešlija D, Cocchiglia S, et al. Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy. Clin Cancer Res. 2015;21:5371-9 pubmed publisher
  154. Bacallao K, Plaza Parrochia F, Cerda A, Gabler F, Romero C, Vantman D, et al. Levels of Regulatory Proteins Associated With Cell Proliferation in Endometria From Untreated Patients Having Polycystic Ovarian Syndrome With and Without Endometrial Hyperplasia. Reprod Sci. 2016;23:211-8 pubmed publisher
  155. Rowson Hodel A, Manjarin R, Trott J, Cardiff R, Borowsky A, Hovey R. Neoplastic transformation of porcine mammary epithelial cells in vitro and tumor formation in vivo. BMC Cancer. 2015;15:562 pubmed publisher
  156. Shah S, Miller P, Garcia Contreras M, Ao Z, Machlin L, Issa E, et al. Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype. Cancer Biol Ther. 2015;16:1671-81 pubmed publisher
  157. Wardell S, Nelson E, Chao C, Alley H, McDonnell D. Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader. Endocr Relat Cancer. 2015;22:713-24 pubmed publisher
  158. Felzen V, Hiebel C, Koziollek Drechsler I, Reißig S, Wolfrum U, Kögel D, et al. Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function. Cell Death Dis. 2015;6:e1812 pubmed publisher
  159. Kawai M, Nakashima A, Kamada S, Kikkawa U. Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family. J Biomed Sci. 2015;22:48 pubmed publisher
  160. Mundim F, Pasini F, Brentani M, Soares F, Nonogaki S, Waitzberg A. MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Mol Clin Oncol. 2015;3:506-514 pubmed
  161. Cheung S, Boey Y, Koh V, Thike A, Lim J, Iqbal J, et al. Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat. 2015;152:489-98 pubmed publisher
  162. Ma S, Yin N, Qi X, Pfister S, Zhang M, Ma R, et al. Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER). Oncotarget. 2015;6:13320-33 pubmed
  163. Koh V, Lim J, Thike A, Cheok P, Thu M, Tan V, et al. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Breast Cancer Res Treat. 2015;152:293-304 pubmed publisher
  164. Winczura P, Sosińska Mielcarek K, Duchnowska R, Badzio A, Lakomy J, Majewska H, et al. Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients. Pathol Oncol Res. 2015;21:1229-36 pubmed publisher
  165. Ferguson D, Long D, Smith M, Craig Owens L, Means J, Fadare O, et al. Comparative analysis of Rb1, P16 and ER as diagnostic, prognostic and potential targets for therapeutic agents in ovarian epithelial tumors: an immunohistochemical study of 130 ovarian carcinomas. J Ovarian Res. 2015;8:34 pubmed publisher
  166. de Deus Moura R, Carvalho F, Bacchi C. Breast cancer in very young women: Clinicopathological study of 149 patients ≤25 years old. Breast. 2015;24:461-7 pubmed publisher
  167. Teng Y, Radde B, Litchfield L, Ivanova M, Prough R, Clark B, et al. Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells. J Biol Chem. 2015;290:15799-811 pubmed publisher
  168. Nwafor C, Keshinro S. Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-Saharan breast cancer cases: Private practice experience. Niger J Clin Pract. 2015;18:553-8 pubmed publisher
  169. Frithiof H, Welinder C, Larsson A, Rydén L, Aaltonen K. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation. J Transl Med. 2015;13:126 pubmed publisher
  170. Zhao H, Agazie Y. Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment. BMC Cancer. 2015;15:109 pubmed publisher
  171. de los Ángeles Carrasco Ruiz M, García Villamar V, López García K, Sánchez García O, Pacheco P, Cuevas E, et al. Aromatase expression is linked to estrogenic sensitivity of periurethral muscles in female rabbits. Cell Biochem Funct. 2015;33:188-95 pubmed publisher
  172. Lee J, Garbe J, Vrba L, Miyano M, Futscher B, Stampfer M, et al. Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Front Cell Dev Biol. 2015;3:13 pubmed publisher
  173. Tkalia I, Vorobyova L, Grabovoy A, Svintsitsky V, Tarasova T. The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats. Exp Oncol. 2015;37:30-5 pubmed
  174. Falkenberg N, Anastasov N, Schaub A, Radulovic V, Schmitt M, Magdolen V, et al. Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221. Oncotarget. 2015;6:8103-14 pubmed
  175. Carnesecchi J, Malbouyres M, de Mets R, Balland M, Beauchef G, Vié K, et al. Estrogens induce rapid cytoskeleton re-organization in human dermal fibroblasts via the non-classical receptor GPR30. PLoS ONE. 2015;10:e0120672 pubmed publisher
  176. Geels Y, van der Putten L, van Tilborg A, Lurkin I, Zwarthoff E, Pijnenborg J, et al. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Gynecol Oncol. 2015;137:245-51 pubmed publisher
  177. Eom K, Jang M, Park S, Kang E, Kim S, Kim J, et al. The Expression of Carbonic Anhydrase (CA) IX/XII and Lymph Node Metastasis in Early Breast Cancer. Cancer Res Treat. 2016;48:125-32 pubmed publisher
  178. Quiroga Garza G, Lee J, El Naggar A, Black J, Amrikachi M, Zhai Q, et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: more aggressive than previously reported. Hum Pathol. 2015;46:725-31 pubmed publisher
  179. Rusz O, Vörös A, Varga Z, Kelemen G, Uhercsák G, Nikolényi A, et al. One-Year Neoadjuvant Endocrine Therapy in Breast Cancer. Pathol Oncol Res. 2015;21:977-84 pubmed publisher
  180. Kim S, Lee Y, Koo J. Differential expression of lipid metabolism-related proteins in different breast cancer subtypes. PLoS ONE. 2015;10:e0119473 pubmed publisher
  181. Hussain I, Bhan A, Ansari K, Deb P, Bobzean S, Perrotti L, et al. Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer. Biochim Biophys Acta. 2015;1849:697-708 pubmed publisher
  182. Heskamp S, Boerman O, Molkenboer Kuenen J, Wauters C, Strobbe L, Mandigers C, et al. Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients. PLoS ONE. 2015;10:e0117745 pubmed publisher
  183. Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed publisher
  184. Simons M, Nagtegaal I, Overbeek L, Flucke U, Massuger L, Bulten J. A patient with a noninvasive mucinous ovarian borderline tumor presenting with late pleural metastases. Int J Gynecol Pathol. 2015;34:143-50 pubmed publisher
  185. Muscatello L, Sarli G, Beha G, Asproni P, Millanta F, Poli A, et al. Validation of tissue microarray for molecular profiling of canine and feline mammary tumours. J Comp Pathol. 2015;152:153-60 pubmed publisher
  186. Argon A, Şener A, Zekioğlu O, Kapkaç M, Özdemir N. The effect of freezing on the immunoprofile of breast carcinoma cells. Balkan Med J. 2014;31:335-9 pubmed publisher
  187. Park S, Kim H, Koo J. Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer. Breast Cancer Res Treat. 2015;149:727-41 pubmed publisher
  188. Li Y, Wu Y, Abbatiello T, Wu W, Kim J, Sarkissyan M, et al. Slug contributes to cancer progression by direct regulation of ERα signaling pathway. Int J Oncol. 2015;46:1461-72 pubmed publisher
  189. Hole S, Pedersen A, Hansen S, Lundqvist J, Yde C, Lykkesfeldt A. New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane. Int J Oncol. 2015;46:1481-90 pubmed publisher
  190. Ammar A, Esmat A, Hassona M, Tadros M, Abdel Naim A, Guns E. The effect of pomegranate fruit extract on testosterone-induced BPH in rats. Prostate. 2015;75:679-92 pubmed publisher
  191. Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz E, Cappello A, et al. Effects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblasts. Environ Health Perspect. 2015;123:493-9 pubmed publisher
  192. Papanikolaou V, Stefanou N, Dubos S, Papathanasiou I, Palianopoulou M, Valiakou V, et al. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes. Cell Oncol (Dordr). 2015;38:155-64 pubmed publisher
  193. Doberstein K, Milde Langosch K, Bretz N, Schirmer U, Harari A, Witzel I, et al. L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor. BMC Cancer. 2014;14:958 pubmed publisher
  194. Liu J, Yu Y, Sun J, He S, Wang X, Yin J, et al. Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast. Breast Cancer Res Treat. 2015;149:133-40 pubmed publisher
  195. Van Bragt M, Hu X, Xie Y, Li Z. RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. elife. 2014;3:e03881 pubmed publisher
  196. Ohoka N, Nagai K, Hattori T, Okuhira K, Shibata N, Cho N, et al. Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway. Cell Death Dis. 2014;5:e1513 pubmed publisher
  197. Tkalia I, Vorobyova L, Grabovoy A, Svintsitsky V, Tarasova T, Lukyanova N, et al. Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor. Exp Oncol. 2014;36:184-90 pubmed
  198. Baccelli I, Stenzinger A, Vogel V, Pfitzner B, Klein C, Wallwiener M, et al. Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients. Oncotarget. 2014;5:8147-60 pubmed
  199. Crider A, Thakkar R, Ahmed A, Pillai A. Dysregulation of estrogen receptor beta (ERβ), aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum disorder subjects. Mol Autism. 2014;5:46 pubmed publisher
  200. Carvalho F, Bacchi L, Pincerato K, van de Rijn M, Bacchi C. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil. BMC Womens Health. 2014;14:102 pubmed publisher
  201. Oguz Erdogan A, Ozdemirler N, Oyken M, Alper M, Erson Bensan A. ARID3B expression in primary breast cancers and breast cancer-derived cell lines. Cell Oncol (Dordr). 2014;37:289-96 pubmed publisher
  202. Li L, Wang Q, Lv X, Sha L, Qin H, Wang L, et al. Expression and localization of estrogen receptor in human breast cancer and its clinical significance. Cell Biochem Biophys. 2015;71:63-8 pubmed publisher
  203. Peña C, Champagne F. Neonatal overexpression of estrogen receptor-? alters midbrain dopamine neuron development and reverses the effects of low maternal care in female offspring. Dev Neurobiol. 2015;75:1114-24 pubmed publisher
  204. Mingels M, Masadah R, Geels Y, Otte Holler I, de Kievit I, van der Laak J, et al. High prevalence of atypical hyperplasia in the endometrium of patients with epithelial ovarian cancer. Am J Clin Pathol. 2014;142:213-21 pubmed publisher
  205. Ucher A, Ranjit S, Kadungure T, Linehan E, Khair L, Xie E, et al. Mismatch repair proteins and AID activity are required for the dominant negative function of C-terminally deleted AID in class switching. J Immunol. 2014;193:1440-50 pubmed publisher
  206. Ulrich D, Tan K, Deane J, Schwab K, Cheong A, Rosamilia A, et al. Mesenchymal stem/stromal cells in post-menopausal endometrium. Hum Reprod. 2014;29:1895-905 pubmed publisher
  207. Wright P, Jones S, Ardern N, Ward R, Clarke R, Sotgia F, et al. 17?-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells. Oncotarget. 2014;5:3055-65 pubmed
  208. Castilla M, Lopez Garcia M, Atienza M, Rosa Rosa J, Díaz Martín J, Pecero M, et al. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer. Endocr Relat Cancer. 2014;21:587-99 pubmed publisher
  209. Aguilar H, Urruticoechea A, Halonen P, Kiyotani K, Mushiroda T, Barril X, et al. VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res. 2014;16:R53 pubmed publisher
  210. Tannour Louet M, Han S, Louet J, Zhang B, Romero K, Addai J, et al. Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action. Nat Med. 2014;20:715-24 pubmed publisher
  211. Feng Q, Zhang Z, Shea M, Creighton C, Coarfa C, Hilsenbeck S, et al. An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Res. 2014;24:809-19 pubmed publisher
  212. Ordonez N, Sahin A. Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study. Hum Pathol. 2014;45:1529-40 pubmed publisher
  213. Varghese F, Bukhari A, Malhotra R, De A. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE. 2014;9:e96801 pubmed publisher
  214. Wang Y, Zhou D, Chen S. SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1. Mol Endocrinol. 2014;28:935-48 pubmed publisher
  215. van der Post R, Bult P, Vogelaar I, Ligtenberg M, Hoogerbrugge N, van Krieken J. HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma. Virchows Arch. 2014;464:673-9 pubmed publisher
  216. Wong P, Yeoh C, Ahmad A, Chelala C, Gillett C, Speirs V, et al. Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer. Oncogene. 2014;33:4579-88 pubmed publisher
  217. Mountzios G, Aivazi D, Kostopoulos I, Kourea H, Kouvatseas G, Timotheadou E, et al. Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes. PLoS ONE. 2014;9:e91407 pubmed publisher
  218. Bouchekioua Bouzaghou K, Poulard C, Rambaud J, Lavergne E, Hussein N, Billaud M, et al. LKB1 when associated with methylatedER? is a marker of bad prognosis in breast cancer. Int J Cancer. 2014;135:1307-18 pubmed publisher
  219. Liu Y, Nenutil R, Appleyard M, Murray K, Boylan M, Thompson A, et al. Lack of correlation of stem cell markers in breast cancer stem cells. Br J Cancer. 2014;110:2063-71 pubmed publisher
  220. Gao L, Yue M, Davis J, Hyjek E, Schuger L. In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor. Virchows Arch. 2014;464:495-503 pubmed publisher
  221. Neumeister V, Parisi F, England A, Siddiqui S, Anagnostou V, Zarrella E, et al. A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue. Lab Invest. 2014;94:467-74 pubmed publisher
  222. Kővári B, Rusz O, Schally A, Kahan Z, Cserni G. Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive. APMIS. 2014;122:824-31 pubmed publisher
  223. Booth M, Hanby A, Speirs V. Steroid hormone receptor expression in breast cancer stroma. Breast Cancer Res Treat. 2014;143:605-7 pubmed publisher
  224. Park H, Jang M, Kim E, Kim H, Lee H, Kim Y, et al. High EGFR gene copy number predicts poor outcome in triple-negative breast cancer. Mod Pathol. 2014;27:1212-22 pubmed publisher
  225. Wang Y, Xu W, Zhou D, Neckers L, Chen S. Coordinated regulation of serum- and glucocorticoid-inducible kinase 3 by a C-terminal hydrophobic motif and Hsp90-Cdc37 chaperone complex. J Biol Chem. 2014;289:4815-26 pubmed publisher
  226. Chavez Valdez R, Martin L, Razdan S, Gauda E, Northington F. Sexual dimorphism in BDNF signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1. Neuroscience. 2014;260:106-19 pubmed publisher
  227. Samaan S, Tranchevent L, Dardenne E, Polay Espinoza M, Zonta E, Germann S, et al. The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways. Nucleic Acids Res. 2014;42:2197-207 pubmed publisher
  228. Faupel Badger J, Duggan M, Sherman M, Garcia Closas M, Yang X, Lissowska J, et al. Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland. Horm Cancer. 2014;5:42-50 pubmed publisher
  229. Yoshimaru T, Komatsu M, Matsuo T, Chen Y, Murakami Y, Mizuguchi K, et al. Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells. Nat Commun. 2013;4:2443 pubmed publisher
  230. Kusafuka K, Onitsuka T, Muramatsu K, Miki T, Murai C, Suda T, et al. Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses. Head Neck. 2014;36:E28-35 pubmed publisher
  231. Kuhn E, Ayhan A, Shih I, Seidman J, Kurman R. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. Eur J Cancer. 2013;49:3839-49 pubmed publisher
  232. Dewaele B, Przybyl J, Quattrone A, Finalet Ferreiro J, Vanspauwen V, Geerdens E, et al. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma. Int J Cancer. 2014;134:1112-22 pubmed publisher
  233. Zhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y. An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy. Int J Clin Exp Pathol. 2013;6:1380-91 pubmed
  234. Kourelis K, Tsue T, Girod D, Tawfik O, Sykes K, Shnayder Y. Negative prognostic factors for head and neck cancer in the young. J BUON. 2013;18:459-64 pubmed
  235. Aguiar F, Mendes H, Cirqueira C, Bacchi C, Carvalho F. Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ. Clinics (Sao Paulo). 2013;68:638-43 pubmed publisher
  236. Hao J, Yang C, Liu F, Yang Y, Li S, Li W, et al. Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review. Cancer Biol Med. 2012;9:197-201 pubmed publisher
  237. Im S, Choi H, Yoo C, Jung J, Jeon Y, Suh Y, et al. Hedgehog related protein expression in breast cancer: gli-2 is associated with poor overall survival. Korean J Pathol. 2013;47:116-23 pubmed publisher
  238. Palmieri C, Gojis O, Rudraraju B, Stamp Vincent C, Wilson D, Langdon S, et al. Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance. Br J Cancer. 2013;108:2039-44 pubmed publisher
  239. Zhao Y, Li W, Lang R, Yang Y, Gao X, Zheng Y, et al. Primary acinic cell carcinoma of the breast: a case report and review of the literature. Int J Surg Pathol. 2014;22:177-81 pubmed publisher
  240. Yang B, Ma C, Chen Z, Yi W, McNutt M, Wang Y, et al. Correlation of immunoglobulin G expression and histological subtype and stage in breast cancer. PLoS ONE. 2013;8:e58706 pubmed publisher
  241. Ward J, Rider V, Abdou N, Kimler B. Estradiol differentially regulates calreticulin: a potential link with abnormal T cell function in systemic lupus erythematosus?. Lupus. 2013;22:583-96 pubmed publisher
  242. Corrêa N, Kuasne H, Faria J, Seixas C, Santos I, Abreu F, et al. Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors. Oncol Rep. 2013;29:1299-307 pubmed publisher
  243. Welsh A, Harigopal M, Wimberly H, Prasad M, Rimm D. Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5. Appl Immunohistochem Mol Morphol. 2013;21:139-47 pubmed publisher
  244. Carvalho F, Carvalho J, Pereira R, Ceccato B, Lacordia R, Baracat E. Leiomyomatosis peritonealis disseminata associated with endometriosis and multiple uterus-like mass: report of two cases. Clin Med Insights Case Rep. 2012;5:63-8 pubmed publisher
  245. Cheah P, Looi L, Lee G, Teoh K, Mun K, Nazarina A. Unusual finding of endocervical-like mucinous epithelium in continuity with urothelium in endocervicosis of the urinary bladder. Diagn Pathol. 2011;6:56 pubmed publisher
  246. Teng Y, Tan W, Thike A, Cheok P, Tse G, Wong N, et al. Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy. Breast Cancer Res. 2011;13:R35 pubmed publisher
  247. Rasmussen L, Frederiksen K, Din N, Galsgaard E, Christensen L, Berchtold M, et al. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells. Endocr Relat Cancer. 2010;17:809-22 pubmed publisher
  248. Leong A, Haffajee Z. Citraconic anhydride: a new antigen retrieval solution. Pathology. 2010;42:77-81 pubmed publisher
  249. Kim T, Huh J, Lee S, Kang H, Kim G, An H. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology. 2008;53:48-55 pubmed publisher
  250. Shi S, Liu C, Pootrakul L, Tang L, Young A, Chen R, et al. Evaluation of the value of frozen tissue section used as "gold standard" for immunohistochemistry. Am J Clin Pathol. 2008;129:358-66 pubmed publisher
  251. Dhasarathy A, Kajita M, Wade P. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol. 2007;21:2907-18 pubmed
  252. Duss S, André S, Nicoulaz A, Fiche M, Bonnefoi H, Brisken C, et al. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells. Breast Cancer Res. 2007;9:R38 pubmed
  253. Rao K, Alper O, Opheim K, Bonnet G, Wolfe K, Bryant E, et al. Cytogenetic characterization and H-ras associated transformation of immortalized human mammary epithelial cells. Cancer Cell Int. 2006;6:15 pubmed
  254. Jones L, Li M, Halama E, Ma Y, Lubet R, Grubbs C, et al. Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer. Oncogene. 2005;24:3554-62 pubmed
  255. Kuo K, Chen M, Lin M. Epithelioid trophoblastic tumor of the broad ligament: a case report and review of the literature. Am J Surg Pathol. 2004;28:405-9 pubmed
  256. Goyal H, Braden T, Williams C, Dalvi P, Mansour M, Mansour M, et al. Abnormal morphology of the penis in male rats exposed neonatally to diethylstilbestrol is associated with altered profile of estrogen receptor-alpha protein, but not of androgen receptor protein: a developmental and immunocytochemical study. Biol Reprod. 2004;70:1504-17 pubmed
  257. Halperin R, Zehavi S, Hadas E, Habler L, Bukovsky I, Schneider D. Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination. Int J Gynecol Cancer. 2003;13:32-7 pubmed
  258. Herbert M, Sandbank J, Liokumovich P, Yanai O, Pappo I, Karni T, et al. Breast hamartomas: clinicopathological and immunohistochemical studies of 24 cases. Histopathology. 2002;41:30-4 pubmed
  259. Halperin R, Zehavi S, Hadas E, Habler L, Bukovsky I, Schneider D. Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma. Int J Gynecol Pathol. 2001;20:341-5 pubmed
  260. Park W, Choi J, Hwang E, Lee J. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas. Clin Cancer Res. 1996;2:2029-35 pubmed